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ABSTRACT
This dissertation describes the integration of micro-scale separations to matrix
assisted laser desorption and ionization time-of-flight mass spectrometry (MALDI TOF MS)
for protein analysis. MALDI MS provides unsurpassed accurate mass measurements of
intact bio-molecules, for example peptides and proteins, which in turn generate high
molecular specificity enabling the identity, function and structure of these molecules to be
characterized. However, in order to realize the full potential of MS in proteomic studies,
integrated sample processing on automated and high throughput platforms is required to
address the complexity, diversity and the dynamic range of proteomic analysis. The work
described here contributes towards the development of automated and high throughput
micro-total analysis systems (µ-TAS) for proteomics.
An overview of mass spectrometry instrumentation and techniques used in protein
analysis is presented to highlight the significance of the work described. Microfluidics
devices can serve as automated and high throughput platforms for integrating proteomics
sample processing steps such as whole cell lyses, enrichment, solubilization, denaturation,
protein separations, proteolytic digestion and chromatographic separations of peptides prior
to MALDI TOF MS analysis. Therefore, coupling microfluidics devices to biological mass
spectrometry is the first logical step towards developing fully integrated and automated
systems for protein analysis. On-line and off-line approaches for analysis from microfluidic
devices are discussed. The development of a specially tailored rotating ball inlet for
automated on-line MALDI MS sample introduction from an electrophoresis-based
separation platform is described. Electrophoresis-based micro-scale separations of peptides
on fused silica capillary and polymer-based microfluidic devices were coupled to on-line

xvi

MALDI TOF MS using a rotating ball inlet. The rotating ball inlet allowed for individual
technique optimization and automation thereby eliminating the need for fractionation and
routine MALDI sample preparation. High throughput solid phase micro-reactors for efficient
enzymatic cleavages and improved protein identification with MALDI MS in a microfluidic
device were also developed for incorporation in an integrated protein analysis microfluidic
system. Future work that outlines the framework and focus geared towards integrating the
modules discussed in this dissertation into a functional micro-total analysis system for
protein sample processing is discussed.

xvii

CHAPTER 1. INTRODUCTION
1.1

Proteins
Proteins are biological macromolecules that consist of one or more polypeptides. A

polypeptide is a linear sequence (chain) of amino acids linked together by covalent peptide
(amide) bonds. An amino acid is an amphoteric (zwitterionic) molecule that contains a basic
amine functional group, an acidic carboxylic acid functional group and a side chain group
designated R as illustrated below. A short amino acid oligomer joined by an amide bond is
called a peptide. When multiple peptide subunits are linked by peptide bonds, they form a
polypeptide or a protein molecule. There are twenty known standard amino acids, which
combine to form every single protein in the human body. Table 1.1 is a list the twenty
known standard amino acids and their physicochemical properties.
O
H2N

CH

C

O

OH

H2N

CH

C

O
NH

R1

R

CH C

OH

R2

Peptide bond
Amino acid

The chemically diverse R groups allows the synthesis of proteins with a wide range
of physicochemical properties. The R side group is specific to each amino acid and is used to
classify amino acids as either weak acids, weak bases, hydrophilic or hydrophobic. For
example glycine, the simplest amino acid molecule, has hydrogen as the side group, and is
classified as hydrophobic. The ionization constant (pKa’s) of the amine and carboxylic
groups in glycine amino acid molecule are 2.35 and 9.78, respectively. The isoelectric point
(pI), value of 6.06 for this amino acid listed in Table 1.1 is therefore an average of the pKa
values of the functional groups in the molecule.

1

Table 1.1 A list of the standard 20 amino acids and their physicochemical properties.
Amino acid

Abbrev. Side chain (R)

Side chain

pK1

pK2

pKr

property

(COOH)

(+NH3) (R)

pI

Alanine

Ala, A

-CH3

hydrophobic

2.35

9.87

Cysteine

Cys, C

-CH2SH

hydrophobic

1.92

10.70

8.18

5.05

Aspartate

Asp, A

-CH2COOH

acidic

1.99

9.90

3.90

2.85

Glutamate

Glu, G

-CH2CH2COOH

acidic

2.10

9.47

4.07

3.15

Phenyalanine

Phe, P

-CH2C6H5

hydrophobic

2.20

9.31

5.49

Glycine

Gly, G

-H

hydrophobic

2.35

9.78

6.06

Histidine

His, H

-CH2-C3H3N2

Basic

1.80

9.33

Isoluecine

IIe, I

hydrophobic

2.32

9.76

6.05

Lysine

Lys, K

-(CH2)4NH2

Basic

2.16

9.06

10.54 9.60

Leucine

Lue, L

-CH2CH(CH3)2

hydrophobic

2.33

9.74

6.01

Methionine

Met, M

-CH2CH2SCH3

hydrophobic

2.13

9.28

5.74

Asparagine

Asn, N

-CH2CONH2

hydrophobic

2.14

8.72

5.41

Proline

Pro, P

-CH2CH2CH2-

hydrophobic

1.95

10.64

6.30

Glutamine

Gln , Q

-CH2CH2CONH2

hydrophilic

2.17

9.13

5.65

Arginine

Arg, R

-(CH2)3NH-

Basic

1.82

8.99

-CH(CH3)CH2CH3

6.01

6.04

7.60

12.48 10.76

C(NH)NH2
Serine

Ser, S

-CH2OH

hydrophilic

2.19

9.21

5.68

Threonine

Thr, T

-CH(OH)CH3

hydrophilic

2.09

9.10

5.60

Valine

Val, V

-CH(CH3)2

hydrophobic

2.39

9.74

6.00

Tryptophan

Trp, W

-CH2C8H6N

hydrophobic

2.46

9.41

5.89

Tyrosine

Try, Y

-CH2-C6H4OH

hydrophobic

2.20

9.21

10.46 5.64
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1.2

Protein Structure
The amino acid sequence forms the primary structure of a protein.1 The peptide

bond is oriented in a trans-configuration such that the carbonyl oxygen and the amide
hydrogen of the adjacent amino acids point away from each other. 2
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Although the peptide bond is rigid, the other bonds are flexible and allow the
polypeptide backbone to fold in space. Therefore, proteins are not linear molecules as
suggested by the amino acid sequence, but rather folds into secondary, tertiary and
quaternary structures.3, 4 Folding of a linear chain is stabilized by intramolecular hydrogen
bonding within the peptide backbone resulting in local protein secondary structures, such as
the alpha (α) helix and beta (β) sheet as shown in Figure 1.1. The alpha helix is
characterized by hydrogen bonds between the co-axial main chain carbonyl (C=O) of each
residue and the amide (N-H) residues along the chain. The beta sheet is characterized by
hydrogen bonds crossing between chains. For long chains, the folding results into a threedimensional domain structure that is unique to each protein. The overall three-dimensional
structure of a single protein molecule resulting from stabilized secondary structures is called
a tertiary structure. A tertiary structure is stabilized by non-bonding interactions, such as the
formation of a hydrophobic core, hydrogen bonds and covalent disulfide bonds between

3

thiol group sulfur atoms in cysteine residues. Proteins further interact with other protein
subunits to form a larger protein complex, called quaternary structures.5 In the context of
functional rearrangements, tertiary or quaternary structures are referred to as
"conformations," and can undergo conformational changes (transitions) induced by the
binding of a substrate molecule to an enzyme's or antibody's active site, a physical region of
the protein that participates in chemical catalysis or molecular recognition.

Figure 1.1 Illustration of primary (amino acid sequence), secondary (α-helix, β-sheet),
tertiary and quaternary (functional) structures of proteins.
1.3

Protein Classification
Proteins can be classified into three main types based on their tertiary structures;

globular proteins, fibrous proteins, and membrane proteins. Most globular proteins are
spherical in shape with their apolar motif oriented towards the inner core while the polar
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moieties are oriented towards the outside. For this reason they are known to be soluble in
aqueous media or less soluble forming a colloidal solution in aqueous media. Examples of
globular proteins are enzymes that catalyze reactions (i.e. esterases), messengers that
regulate biological processes (i.e. hormones) and other proteins like hemoglobin and
immunoglobulins. Fibrous proteins are long filamentous molecules that serve as structural or
storage proteins and are used to construct connective tissues, tendons, bone matrix and
muscle fiber. They are insoluble in aqueous media and aggregate due to hydrophobic side
groups that stick out of the molecule. Examples of fibrous proteins are keratins, collagens
and elastins. Lastly, membrane proteins are covalently attached to, or electrostatically
associated with the membrane of a cell or an organelle. They often serve as receptors or
provide channels for polar or charged molecules to pass through the cell membrane. In terms
of physical properties, proteins can also be divided into acidic, basic, hydrophobic and
hydrophilic proteins depending on their amino acid composition.
1.4

Protein Synthesis
Proteins are bio-synthesized from genetic codes, a set of three-nucleotide sequences

called codons present in the genome, that specify particular amino acid information encoded
in the messenger ribonucleic acid (mRNA) of a given cell as illusrated in Figure 1.2.6, 7 RNA
and DNA molecules are made up of four different types of nucleotides linked together by
phosphodiester bonds. However, they differ chemically in that nucleotides in RNA contain
the sugar ribose rather than deoxyribose as in DNA. Like DNA, RNA contains the bases,
adenine (A), guanine (G) and cytosine (C), however RNA has the base uracil (U) instead of
thymine (T) as in DNA. In the first step of protein bio-synthesis, transcription, the double
helix deoxyribonucleic acid (DNA) strands in a gene that codes for a protein unzips and the
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strands unwind from each other to expose the code on each DNA strand.8 There are about
six possible reading frames on double stranded DNA, three forward and three reverse. A
reading frame contains a set of three adjacent and non-overlapping nucleotide codons in
DNA or RNA. A reading frame that contains both a start and a stop codon is called an open
reading frame (ORF). A protein enzyme called RNA polymerase, reads the sequence of
nucleotides in the codon of one of the DNA strand that serves as the template and
synthesizes a single strand mRNA molecule from the 5 -to-3 direction. The sequence of the
RNA chain (transcript) produced by transcription is determined by the complementary base
paring between the growing RNA nucleotides and the DNA template. The RNA chain is
thereafter displaced and the DNA double-helix reforms.
The single stranded mRNA once released from the DNA template migrates from the
nucleus to the ribosomes in the cytoplasm and is translated into a transfer RNA (tRNA). In
the second step, translation, ribosome translates the codons from the mRNA that specify the
order in which new amino acids are added by the initiator, tRNA, to a growing protein chain
for elongation.9 The amino acid assembly is linked together by peptide bonds eventually
forming a protein that is later released by the tRNA.10 Different proteins can be generated by
alternative use of start and stop codons. Cells also have the ability to change the protein
expression levels depending on the state of the cell. Regulatory regions of DNA near the
sites where transcription starts may act as a switch and respond to a signal from the cell to
control gene expression while other regulatory regions serves as a microprocessor and
respond to a variety of signals from the cell to control gene expression. For example the
gene regulatory proteins can turn specific sets of genes on or off, hence, regulating protein
expression levels in the cell.

6

Figure 1.2 Protein synthesis steps in a cell; (a) transcription at genetic level, (b) posttranscription at the mRNA level (c) translation at the tRNA level (d) post- translation at the
protein level.
Synthesized proteins can be modified further in various ways (> 400) during or after
translation.11 Post-translational modifications can occur either through attaching functional
groups to specific amino acid chains on the protein, attaching other proteins or peptides,
changing the chemical nature of amino acids or involving structural changes. Whereas some
post-translational modifications such as glycosylation are permanent, others like
phosphorylation are transitional and are used for cell cycle regulation. The genome
(complete set of genes in an organism) is static while the transcriptome (complete set of
RNA in a given cell) and the proteome (complete set of proteins in a given cell, tissue,
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organelle or body fluid) are dynamic due to the regulation of transcription, RNA processing,
protein synthesis and protein modifications. For example, the human genome has ~30,000
genes that can generate over 106 proteins when post-translations modifications are taken into
account.11
1.5

Protein Function
Proteins are involved in most cellular processes as enzymes that catalyze

biochemical reactions within the cell, such as metabolism, catabolism, DNA replications,
DNA repair and RNA synthesis.12-14 Enzymes, that are proteins, also act on other proteins
involved in signal transduction and in regulation of the cell cycle. Proteins act as receptors
and cell adhesion molecules to transport ligands through the cell and through the body and
to recognize extra cellular stimuli and signaling molecules, for example hemoglobin and
antibodies. Other proteins play structural or mechanical roles, such as in the cytoskeleton,
which allows the cell to maintain its shape and size. The mechanisms for controlling these
functions often depend on controlling protein activity. Activity is regulated by posttranslational modifications either through attaching functional groups to specific amino acid
residues on the protein, attaching other proteins or peptides, changing the chemical nature of
amino acids or inducing structural changes. Examples of post-translational modifications
include addition of functional groups as in acetylation, alkylation, phosphorylation and
glycosylation to specific amino acid residues, addition of other proteins/peptides as in
ubiquitination, changing of amino acids as in deamidation and other structural changes due
to disulfide bridges and proteolysis. Most of the protein’s post-translational modifications
could serve to increase or decrease in activity, lifetime, or both and hence extend the range
of protein functions.11 For example, acetylation of the N-terminus increases the lifespan of
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proteins in the cell while phosphorylation is used to activate or deactivate enzymes and to
modulate the specificity of receptors.
1.6

Why Analyze Proteins?
Following the elucidation of the genome sequences of many organisms, there has

been a shift in focus from genomics, the study of global properties and functions of genes, to
proteomics, which is the large-scale study of identity, structures, functions, interactions and
expression levels of proteins that form complete sets of proteins (proteome) of a given
organisms, organelle, tissue or cell line.12 Genomic information is of great use to proteomic
studies because it provides a “blueprint” of the probable complementary proteome. Since
proteomics relies on the existence of genomic information, it plays the role of identifying
and defining functional genomic codes from a given DNA sequence along with annotating
the genome.15 As a result, proteomic studies have focused on a large-scale characterization
of the entire protein complement of a cell line, tissue or organism, protein-protein and
protein-gene interactions, modifications, function, and define where these proteins are
located in cellular and sub-cellular compartments. In this regard, the goal of proteomics is to
obtain a global and integrated view of how biological systems function. This information,
when combined with gene expression and metabolic profiling, forms the basis for
understanding the fundamental mechanisms of life, a field known as systems biology.13, 16, 17
Proteomics is currently studied in a number of complementary ways categorized
either under descriptive, structural, interaction, functional, or expression proteomics as
shown in Figure 1.3.18 Descriptive or qualitative proteomics focuses on the identification of
new expressed proteins to validate hypothetical proteins predicted from gene sequences, or
to add new proteins to existing protein databases or to serve as biomarkers for disease
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states.19-21 Proteins are readily accessible in biological samples such as serum, cerebrospinal
fluid and urine when shedding from tissues and can be used as diagnostic, staging and
prognosis disease biomarkers.22,

23

Further, proteins are the most therapeutically relevant

molecules in systems biology, lending themselves as therapeutic agents or for use in
therapeutic drug monitoring studies.24 On the other hand, structural proteomics entails
mapping out the overall structure of proteins and their complexes in an effort to characterize
protein-protein interactions.25, 26 These interactions are useful in drug discovery since they
help in studying protein-drug interactions and activity. Structural proteomics also exposes
post-translational modifications in proteins that alter their activity.
Expression proteomics involves the quantitative study of protein expression levels
between samples that differ by some property e.g. cancer.27-29 Studies have shown that there
is no measurable correlation between expression levels for a given gene transcript, mRNA
quantities and the corresponding proteins quantities.17,

30, 31

One reason being that the

majority of protein diversity is generated post-transcription. The comparison of protein
expression levels within samples that differ by some parameter gives rise to differentially
expressed protein profiles that are used to discover proteins that can serve as biomarkers.
Functional proteomics involves monitoring fluxes, spatial and temporal properties of
molecular networks in living cells in an effort to provide information about pathway
signaling, aging and disease mechanisms or protein-drug interactions.14, 32-34 Another reason
for analyzing proteins rather than the genetic code is that protein activity is dependent on
post-translational modifications, which cannot be predicted from the corresponding DNA
sequence. In terms of location, some proteins move from one cellular compartment to
another, for example from the cytosol to the nucleus, as a form of regulation and in such
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cases, it has been shown that the cellular distribution of a given protein is more informative
than the protein expression level. By identifying the molecular species involved in such
biological networks, proteins can be classified by function. Induced changes in the protein
primary structure and RNA interference also allows for large-scale functional evaluations in
these molecules.

Figure 1.3 Overview of proteomics, which can be categorized into functional proteomics
(defining protein functions and their role in systems biology), structural proteomics
(elucidating structures of proteins, complexes and interactions), expression proteomics
(measurement of protein expression levels and their relation to physiological state of the
cell) and qualitative proteomics (identifying expressed proteins).

1.7

Challenges of Analyzing Proteins
A number of technologies have been developed to analyze proteins; however it is

clear that no one technology platform is suitable for all applications.35 Despite the strengths
and weaknesses of existing technologies, one significant drawback is their lack of
integration and automation. Another limitation of protein analysis is the lack of an
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amplification method equivalent to the polymerase chain reaction (PCR) for preparation of
less abundant proteins that are difficult to detect. The issue of sensitivity becomes
paramount considering the dynamic range of protein abundance in biological samples.36 Its
has been estimated that this dynamic range is in the order of 105 for tissues and 109 for body
fluids such as serum.37 Low abundant proteins are present in nanomolar concentrations (~
10-50 ng/ml or less) in body fluids.37, 38 Therefore, they are difficult to detect in the presence
of high abundant ones (~50-80 mg/ml) due to limited dynamic range of commonly used
technologies. The diversity of proteins between different cell lines even within the same
tissue or organism is still another challenge. Whereas human cells may express up to 20,000
proteins at one time, the approximately 30,000 genes in the human genome may code for
more than 800,000 proteins.15, 39 Further, these proteins can be modified after translation in
over 400 ways.40 These tasks have already brought about a number of intimidating
challenges that continue to prove that a comprehensive study of the proteome is sometimes a
humbling exercise that is far from completion.36,

41

However, a significant progress has

already been realized in the development of techniques for analyzing proteins.42-44 Another
issue with some common technologies is the high rate of false positives and false negatives,
for example, the yeast two-hybrid system, which is used to detect protein interactions.45, 46
1.8

Sample Processing for Proteomics
Typical sample preparation for proteins entails a series of laborious and low

throughput steps ranging from protein extraction methods from tissues such as laser
microdissection, whole cell lyses, protein isolation and enrichment from body fluids,
solubilization, reduction, alkylation and denaturation before gel electrophoresis separation,
staining and spot excision, proteolytic digestion of visualized protein spots, chromatographic
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separations of generated peptide fragments followed by either off-line fractionation or online analysis or both, identification of the peptide fragments and proteins using mass
spectrometry.37,

47

A schematic representation of the routine sequence of analytical steps

used for proteomic sample processing is shown in Figure 1.4.

Figure 1.4 Overview of proteomic sample processing steps and techniques used in the
extraction, pre-concentration, separation, identification and discovery of proteins from
tissues, cells and body fluids.
There are two popular strategies used in analyzing proteins by mass spectrometry,
the “bottom-up” and “shotgun” approaches. In the “bottom-up” approach,48,

49

protein

mixtures are first separated, then the separated proteins are digested before the identification
process by peptide mass fingerprinting or sequence tag is begun as shown in Figure 1.4
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above. Since the digestion step occurs after protein separation, the peptide fragments
generated are specific to a particular protein and in most cases allow identification without
Tandem MS. The “bottom-up” approach is time consuming and limited by the resolution of
two dimensional gel electrophoresis. On the other hand, the “shotgun”

50

approach begins

with proteolytic digestion of protein mixtures followed by a variety of chromatographic
separation approaches as shown in Figure 1.5 below.

Figure 1.5 General strategies used in proteomic studies; shotgun approach begins with the
digestion of all the extracted proteins followed by separation and fractionation before
analysis with a mass spectrometer, the bottom-up approach begins with the separation of all
extracted proteins, followed by staining, digestion and then identification with mass
spectrometry.
For the shotgun approach, digestion of complex proteins mixtures result in a large
number of peptides that cannot be resolved by any analytical technique and also complicates
the protein identification process.51 A combination of multi-dimensional liquid
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chromatography and tandem MS is usually performed to improve the protein identification
efficiency.52 When shotgun and bottom-up approaches are combined, one can sacrifice the
high resolution requirements in two dimensional gel electrophoresis for the bottom-up
approach by extensive fractionation at the peptide level with shotgun protocols. Another less
commonly used approach is “top-down” which typically refers to measuring the mass of a
protein in a mass spectrometer prior to gas phase fragmentation usually by electron capture
dissociation.53-55
1.8.1

Extraction of Proteins

Extraction of protein from tissues, cells and body fluids requires efficient release of
biomolecules since it is the first step in a multi-step sample processing scheme. The quantity
and nature of released proteins affect the success of downstream processing. A general
sample extraction entails removal of salts, nucleic acids, polysaccharides, lipids and
insoluble material. Current technologies for protein extraction employ either mechanical
methods like mortar and pestle grinding, or semi-automated methods, such as bead beating,
rotor-stator homogenizations, enzymatic digestion, chemical dissolution and sonication.56-58
These methods suffer from potential contaminations, extended processing time, shearing
molecules-of-interest that result in distortion of native states of protein complexes, lack of
automation, selective to a subset of proteins or narrow range of sample types and poor
reproducibility.59,

60

They also destroy the protein compartmentalization (localization)

information and release hydrolases (phosphatases, glycosidases and proteases) into the
homogeneous lysate leading to potential alteration of the native protein composition and
rendering differential expression difficuit.37 Some proteins, for example, the plasma
membrane proteins are difficult to isolate due to their propensity to exist in various
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structures and also due to their low abundance in relation to mitochondria, endoplasmic
reticulum and other membranes in the cell.61 Removal of protein disulfide bonds followed
by reduction and alkylation of the resulting free sulfide groups is necessary to improve
solubility.47
New, reliable and improved protein extraction methods are therefore needed to
advance and accelerate proteomic discoveries. First, novel sample processing platforms are
needed to address fast solubilization of all cellular proteins and naturally occurring protein
complexes. The platforms also need to alleviate unwanted protein aggregations, promote
efficient extraction, release and isolation of all protein components (especially 30% of
membrane proteins which constitute more than 50% of current drug targets) from cellular
debris without altering their native form or states in an automated and high throughput
sample processing system.24, 62, 63
1.8.1.1 Pressure Cycling Technology Sample Preparation System (PCT SPS)
The state-of-the-art technology for protein extraction from solid tissues, body fluids,
liquid cultured cells, including a variety of hard-to-lyse materials, employs an automated
pressure cycling technology sample preparation system (PCT SPS).64 The system utilizes a
pressure instrument (barocycler) to generate alternating cycles of ambient and 35 kpsi (235
MPa) of hydrostatic pressure. Samples are placed inside the tubes and then the tubes are
placed inside the barometer for cycles of pressure to be applied. The alternating cycles of
pressure are used to control biomolecular interactions and hence release proteins from cells
and tissues in temperature controlled single use PULSE (pressure utilized to lyse sample for
extraction) tubes shown in Figure 1.6.64, 65
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On one end of the tube is a movable polypropylene ram that is put in place after the
sample is loaded into the tube, on the other end of the tube is a fluid retention chamber
sealed with a threaded cap for introducing processing buffers and withdrawing extracted
samples from the tube. In the middle of the tube there is a perforated lysis disk. The
temperature is controlled using an external circulating water bath to maintain sample
processing between 4 and 370 C. At high pressure, the movable polypropylene ram (disk)
and the perforated lysis disk placed inside the tube squeezes and macerates the solid tissues,
increasing the surface area, which is exposed to the extraction buffer. When the pressure is
released, the partially homogenized sample is pulled back through the lysis disk by the
receding ram. The combination of physical passage through the lysis disk, rapid pressure
changes, temperature, solvent exchange and other bio-physical mechanisms, breaks up the
cellular structures thereby releasing the nucleic acids, small molecules and proteins into the
collection chamber. Proteins are thereafter isolated from the homogenized sample.

Figure 1.6 Pressure used to lyse sample and extract (PULSE) tube consisting of (a) a ram,
(b) a perforated lysis disk, (c) a collection chamber and (d) a threaded cap.
1.8.1.2 Laser Capture Microdissection
Laser capture microdissection employs a finely focused laser beam to isolate
individual cells from a heterogeneous tissue sample section as illustrated in Figure 1.7.66, 67
It is basically an inverted microscope fitted with a low-power near-infrared laser. Tissue
17

sections are placed on standard glass slides, and a transparent, 100-mm-thick, ethylene–
vinyl acetate film placed over the dry tissue section. A focused laser beam with adjusTable
diameter (7 to 30 µm) provides enough energy to transiently melt a thermoplastic film in a
precise location, binding it specifically to the targeted cells. The plastic film absorbs most of
the thermal energy and hence little or no detecTable damage of tissue or biomolecules
occurs. The film with the adhering cells is thereafter lifted off the thin tissue section, leaving
all unwanted cells and tissue behind in contact with the glass slide. Under the microscope,
one views the thin tissue section through the glass slide on which it is mounted and chooses
microscopic clusters of cells to be targeted for extraction and further molecular analysis.
Targeted cells are delivered directly into a microcentrifuge tube, cap or a thermoplastic film
for purification and molecular processing. Proteins are thereafter isolated from these cells
using appropriate protocols. The major limitation of this technique is that it isolates minute
amounts of sample, which limits analysis to the collection of numerous cells for protein
analysis.68 The isolation of large numbers of cells from many tissue sections takes a long
time.

Figure 1.7 Laser capture microdissection apparatus used for selective isolation and
extraction of individual cells from a tissue section. (http://www.nano.geo.unimuenchen.de/nanobio/laser.html).

18

1.8.2

Protein Pre-concentration

After extraction, sample pre-concentration is required to address protein components
present in low amounts. Traditional concentration methods such as solvent evaporation,
molecular weight cut-off filters and dialysis are time consuming, have high sample loss, and
lack selectivity, hence results in contaminants and other proteins being concentrated along
with the targeted proteins. Pre-concentration platforms should address selective depletion of
high abundant proteins. For example, accessible body fluids like blood plasma, is postulated
to have 30,000 proteins. The albumins, immunoglobulin G, alpha-1-antitrypsin,
immunoglobulin A, transferrin and heptaglobin are the most abundant proteins (60-80
mg/ml) while the biologically interesting and clinically relevant low abundant proteins
present in > 10 ng/ml accounts for ~ 15 % of unknown proteins as shown in Figure 1.8.69
Cutting edge techniques in the field utilize bio-specific molecular recognition elements, such
as immuno-affinity ligands,69 zwitterionic detergents, ion-exchange, size exclusion and
separation techniques to deplete the high abundant proteins.70-73

Other
15 %

Haptoglobin 2.9 %
Transferrin 3.3 %

Albumin
54.3 %

IgA 3.4 %
α-1-antitrypsin 3.8 %

IgG
16.6 %

Figure 1.8 Pie chart illustration of human serum proteins; albumin are the most abundant
proteins in serum present in ~ 60-80 mg/ml while the unknown proteins account for 15% of
the serum proteins and are present in less than 10 ng/ml.
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Affinity ligands such as antibodies, antigens, aptamers, enzymes, hormones and
avidin have been used to remove interference by immuno-depletion of high abundant
proteins in order to improve the detection of low abundant proteins.74-76 IgG immunoaffinity-based systems with specific antibodies that target abundant proteins have been
demonstrated to provide effective removal of targeted abundant proteins, with minimal
carryover, high longevity, and minimal nonspecific binding. Immobilized metal ion affinity
chromatography (IMAC) has also been used for protein pre-concentration. IMAC employs a
column material to bind divalent metal ions such as copper, nickel, zinc, cobalt, iron, and
calcium.77-80 For example, these metal ions specifically interact with exposed amino acid
residues like histidines, tryptophans, cysteines, and tyrosines (common phosphorylation
sites) to form coordination complexes between the metals and amino acid residues on the
protein.81-84 This results in affinity enrichment of phosphorylated proteins and serves to
eliminate interferences thereby increasing the signal intensity for protein identification.
Centrifugal ultrafiltration has also been used to pre-concentrate low molecular
weight proteins by using denaturing conditions that disrupt protein-protein interactions.70
The technique can be tuned by varying the spin time, sample amount and protein recovery
method; however, it lacks specificity. Protein pre-concentration has also been demonstrated
from solution by adsorption of a protein or protein mixture onto a hydrophobic resin
immobilized within a microcolumn. Sample loading is accomplished by flowing the protein
solution through the microcolumn, where the protein adsorbs onto the hydrophobic resin
surface.85 Another approach employs microbeads to concentrate proteins from an aqueous
phase by adsorption onto reverse-phase polymer beads.86, 87 The beads are then washed to
remove contaminants before the bound proteins are released from the beads by digestion.
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1.8.3

Protein Separation

Protein separation allows simplification of complex mixtures and improves the
detection of low abundant proteins. A number of separation technologies have been on the
forefront of proteomics studies in efforts to elucidate the identity of proteins. Commonly
used protein separation methodologies, their strengths, limitations and the need for new
enabling technologies are discussed in the following section.
1.8.3.1 One and Two Dimensional Gel Electrophoresis
For a long time, one-dimensional sodium dodecyl sulphate poly-acrylamide gel
electrophoresis (1D SDS PAGE) has been used as the method of choice to resolve protein
mixtures.88 The SDS surfactant denatures proteins by binding along the polypeptide
backbone and hence imparting a negative charge along its length. A reducing agent is added
in order to reduce the disulfide bridges allowing the protein to adopt a random-coil
configuration necessary for separation by size in the cross-linked polyacrylamide sieving gel
matrix cast on a slab upon application of an electric field.88 Protein separations in the crosslinked gel matrix pore structures is based on molecular weight and the technique has a
dynamic range of approximately 10 to 300 kDa. The viscous gel serves as an anticonvective
medium eliminating conductive transport, reducing diffusion and hence increases the
resolving power and peak capacity.
One dimensional gel electrophoresis is limited in resolving power with maximum
peak capacity of ~ 400.89, 90 The low peak capacity results from the fact that the peaks are
restricted to a definite interstitial retention volume and maximum solvent volume of the gel.
For more complex protein mixtures, two-dimensional sodium dodecyl sulphate polyacrylamide gel electrophoresis (2D-SDS PAGE) is usually the method of choice for the
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“bottom-up” approaches.91-93 In two-dimensional gel electrophoresis, proteins are initially
separated based on their isoelectric point (pI) using isoelectric focusing (IEF) and thereafter
separated in the second dimension using SDS PAGE based on their molecular weight. In
IEF, protein mixtures are electrophoretically driven through a pH gradient, and since
proteins are zwitterionic, they migrate to a final position where the net charge is zero.94 The
pH at this point is usually the same as the pI of the protein. The theoretical limit of IEF is
governed by the resolution of the pH gradient. The resolution in IEF can be increased by
using immobilized pH gradients or specialized pH gradients that can zoom in on a narrow pI
range to resolve more complex mixtures.39, 94, 95 The increased resolving power and hence
peak capacity (> 1000) in 2D gel electrophoresis has been used to resolve post-translational
modified proteins and different forms of proteins.
Despite these strengths, a number of limitations to 2D gel electrophoresis still exist.
It remains a laborious and is a slow process taking over 24 h and is capable of a single run
per gel. Although, the dynamic range is wide, it is limited by the number and type of
proteins that can be resolved.47 Loading of hydrophobic proteins is a challenge. For
example, plasma membrane proteins analysis require cleaving of protein disulfide bonds
followed by reduction and alkylation of the resulting free sulfide groups to improve
solubility.47 In addition, most abundant proteins usually dominate the gel thereby making
visualization and detection of low-copy proteins difficult. The technique is widely used for
qualitative and expression profiling where differentially expressed proteins between two
samples that differ by some parameter are exposed by the appearance or disappearance of
spots on the gel.53,
information

97

54, 96

The intensity of the spots on the gel provides quantitative

about protein expression levels while a mass spectrometer is used to identify
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or even quantity the proteins in the gel spots.98-100 A schematic of current equipment used in
2D gel electrophoresis and an example of typical data used for differential display is shown
in Figure 1.9.

Figure 1.9 A representation of current 2D gel electrophoresis equipment which employs IEF
in the first dimension and SDS PAGE in the second dimension. A typical data output is also
shown as used to display differentially expressed proteins in diseased versus normal tissues.
•

Staining

Protein spots resolved in a gel need to be visualized for ease of detection, excision
and identification. Visualization of spots in gel can be done in situ or following “western”
electroblot transfer of separated proteins onto polymeric membrane support materials.101
Most of the staining is done after electrophoresis, however, there have been attempts to stain
proteins before loading them onto the gel.102, 103 Protein spots are visualized using staining
methods such as silver stains, commassie blue, fluorescent dyes or radioactive labels. In situ
staining is required for most proteins using organic dyes for example coomassie blue, which
is a non-polar sulfonated aromatic dye that stains basic amino acid residues in acid
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conditions. It is less sensitive compared to silver stains, which is the most sensitive nonradioactive protein visualization stain. However, silver stains are not universal, they stain
some proteins poorly if not at all, for example calcium binding proteins. Fluorescent dyes,
for example fluorescamine, have also been used to stain proteins before or after gel
separation. Radioactive isotopes such as

14

C,

35

S,

32

P, 3H and

125

I have also been used to

label proteins. Radiolabeling is the most sensitive protein visualization and detection
method. Staining proteins is time consuming and depends on the type of stain, the
visualization and image processing steps adds processing time to sample preparation and
analysis.104
•

Digestion

For identification purposes, visualized protein spots are excised from the gel and
processed using proteolytic digestion or chemical cleavage.105 Chemical reagents used for
digestion, for example cyanogen bromide, cleave peptide bonds at specific amino acid
residues while others like hydrazine cleaves all of the peptide bonds yielding amino-acyl
hydrazides of all the amino acids present in a protein. Most of the protein digestion is carried
out using in-solution or in-gel digestion protocols that take between 6 to 24 hours.105 The
process usually involves protein denaturing, reducing the disulfide bonds, mixing with an
alkylating agent to prevent disulfide bonds from reforming and finally incubation of the
protein mixture with a lytic reagent. Enzymatic proteolytic cleavage employs proteases that
hydrolyse the peptide bond. Proteases are divided into two broad categories: proteinases or
endopeptidases, which attack inside the protein to produce large peptide fragments and the
peptidases or exopeptidases, which attack ends of proteins to produce smaller peptide
fragments or amino acids.106, 107 The proteinases can further be subdivided into six groups
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based on the mechanism of action at the active site. These sub-divisons are serine, cysteine
(thiol), aspartic (acid), metallo and glutamic acid proteases named according to the amino
acid participating in catalysis. On the other hand, peptidases are classified based on the
action pattern: for example, aminopeptidase cleaves amino acids from the amino end,
carboxypeptidase cleaves amino acids from the carboxyl end, dipeptidyl peptidase cleaves
two amino acids, dipeptidase splits a dipeptide and tripeptidase cleaves an amino acid from a
tripeptide.
Examples of serine proteinases such as trypsin, cleaves the peptide bond at the cterminal next to lysine and arginine residues if the residues are not next to praline. Another
serine protease chymotrypsin, cleaves the peptide bond at the c-terminal next to tryptophan
and tyrosine if these residues are not next to proline.108 Other cysteine (thiol) proteinases
include bromelain and papain. Aspartic (acid proteinases) for example pepsin cleave at the
N-terminus next to leucine, tryptophan and tyrosine if the residues are not next to praline.
Examples of metallo-proteinase include collagenase, keratinase and collagenase. Examples
of aminopeptidase include alanyl and lysine aminopeptidase, di and tripeptidase like
lysosomal peptidases. Carboxypeptidase e.g. prolyl carboxypeptidase A does not cleave
when C-terminus residue is arginine, lysine or proline or if proline resides next to terminus
residue.108
1.8.3.2 Liquid Chromatography
Liquid chromatography (LC) is a powerful technique for separating proteins and
peptides. Sample loading in LC is controlled using fixed volume sample loops that are
typically in the micro-liter range. Sample is pumped through the column at 1000-5000 psi
with a flow rate dependent on the column internal diameter (i.d.). Generally, LC is practiced
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in column formats of greater that 10 mm i.d. and at flow rates of 1000 μl/min for prep-scale
purpose. For analytical separations, columns of less than 5 mm i.d. are employed with
varying flow rates. The columns consist of a stationary solid phase such as 5 µm size beads
that interacts with solutes in a mobile liquid phase. Recent developments have shown that
capillary LC, which employs smaller i.d. capillaries of ~ 50 μm or less provide a linear
response over a wide range of sample concentrations and improved sensitivity due to
constrained sample size when interfaced to a mass spectrometer.
LC is practiced in different formats namely; ion exchange, size exclusion, normal
and reverse-phase liquid chromatography. In ion exchange chromatography, proteins are
reversibly adsorbed on to solid phase resins that contain cationic exchangers such as -SO3-, OPO3- and -COO- anionic functional groups or anionic exchanger that contain the cationic
tertiary (i.e. -C2H4NH(C2H5)2) and quaternary (i.e. -CH2N+(CH3)3) ammonium groups to
separate proteins based on their charge properties. Proteins possess a net charge in solution,
dependent upon the pH, structure and pI. In solutions with pH below their pI, proteins have
a net positive charge and will bind to cationic exchangers, whereas in solutions of pH above
their pI they have a net negative charge and will bind to anionic exchangers. The procedure
involves gradient elution using a mobile phase consisting of buffers of gradually increasing
ionic strengths to displace bound proteins from the stationary phase or changing the buffer
pH so that the net charge on the proteins is altered.109
In a different format, size exclusion chromatography also referred to as gel
permeation or gel filtration chromatography, proteins are separated based on their size.110
The columns employ a gel medium such as silica, cross-linked polystyrene, polyacrylamide,
dextran or inert porous agarose beads that trap small proteins in the pores resulting in longer
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retention times compared to large proteins. The pore size is dependent on the gel medium,
for example silica-based medium has a pore size in the range of 125 to 1000 Å and
molecular weight exclusion limit of 2 kDa to 50 kDa for pore sizes of 125 Å, 5 kDa to 500
kDa for pore sizes of 500 Å and so forth. Cross-linked polystyrene-divinylbenzene has pore
sizes in the range of 102 to 106 Å while agarose pore sizes in the range of 500 to 2500 Å.
For a protein domain with an apparent hydrodynamic radius (radius of gyration) of 14 Å
when folded and 36 Å when unfolded, the folded form will elute much later due to its
smaller size.
Normal phase LC employs polar stationary phase such as cyano (-C2H4CN), diol (C3H6OCH2CHOHCH2OH), amino (-C3H6NH2) dimethylamino (-C3H6N(CH3)2) and nonpolar mobile liquid phases to separate proteins based on their polarity. Reverse-phase
chromatography, the most commonly used LC format, employs stationary phases that are
non-polar like hydrocarbons, waxy liquids or bonded hydrocarbons such as C18, C8, C4 .111
One common stationary phase is silica, which has been treated with RMe2SiCl, where R is a
straight chain alkyl group such as C18H37 or C8H17. The mobile phase is comprised of
solvents that are polar-aqueous mixtures like methanol-water or acetonitrile-water. Elution is
accomplished using either a single (isocratic) or a programmed (gradient) mobile phase
composition. Solvophobic interactions of the solutes in the mobile phase and the stationary
phase results in differences in adsorption, selectivity and partitioning. As a result, solute
retention occurs and components in the liquid phase are separated as they elute out of the
column.111
Generally, for large proteins (i.e. with molecular weight above 20 kDa), a digestion
step prior to separation with LC is required. A typical digestion of a protein mixture present
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in a given sample generates a more complicated peptide mixture that no single separation
technique can resolve. For example, the proteome of many cell lines may contain more than
10,000 proteins and a tryptic digest of one protein may result in an average of 30-50
peptides, this translates to ~3 x 105 to 5 x 105 or more peptides. Usually multi-dimensional
LC, typically strong cation exchange followed and reverse-phase LC followed by multiple
fractionation steps, are carried out to address sample complexity of this magnitude.112 A
typical multidimensional LC can resolve up to 2 x 104 peptides in the best-case scenario,
which is still one order of magnitude less than required to analyze all peptides present in the
proteome of a cell line.113, 114 Further, the sample processing, like in the best case scenario
example described above, takes three days of work.114 Nonetheless, liquid chromatography
is the workhorse of “shotgun” proteomics where proteins are digested and the resulting
peptides subjected to multiple LC steps.50, 115 When this LC approach is combined with 2D
gel electrophoresis, one can sacrifice the high resolution in 2D gel electrophoresis at the
protein level by extensive fractionation after LC separations at the peptide level.
1.9

Microfluidic Devices and Systems for Proteomic Sample Processing
A microfluidic device consists of a network of fluidic channels that are a few tens of

microns wide and fabricated in planar substrates such as glass, silicon or polymers. The
fabrication of microfluidic devices is discussed in Chapter 3. Microfluidic devices are being
explored as alternative platforms for protein analysis. On reason being that the transitioning
of analytical techniques to chip-based formats promises potential revolutionary impact on
bioanalytical analyses.116-121 The advantages associated with microfluidic platforms include,
small sample volumes,122,

123

less reagent consumption, disposability, portability, fast
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analysis, parallel analysis, reduced cost

124-126

and integrated sample processing that

eliminates sample losses and contamination.116, 127-129
1.9.1

Microfluidic Devices for Discrete Protein Sample Processing Steps

Samples are usually flowed through a network of channels in a microfludic device for
discrete processing steps like extraction, pre-concentration, separations, sorting, capture,
lyses, digestion, desalting and clean-up.
1.9.1.1 Extraction
Microfluidic devices have been demonstrated for cell lyses and protein extraction.130,
131

In one of these examples, a diffusion-based microfluidic device for continuous lysis of

bacterial cells and fractionation of protein components was reported. A cell suspension and a
chemical lytic reagent were hydrodynamically introduced into the device, the lytic reagent
permeates into the cell membrane allowing intracellular components to leave the cell and
diffuse into the same fluidic channel depending on their size and diffusion coefficients.131 In
a different approach, phosphocholine immobilized on agarose beads was used for solid
phase extraction in a microfluidic device to extract C-reactive protein directly from
unadulterated human serum.132 The beads were packed into the fluidic channel and solution
containing C-reactive protein introduced using a syringe pump. The protein was
subsequently released by changing the elution buffer.
1.9.1.2 Pre-concentration
Microfluidic devices have been used to pre-concentrate protein samples from
solution.133-138 One sample pre-concentration technique employs sample stacking with
buffers plugs of different conductivity.137-140 Dialysis has also been used to pre-concentrate
proteins in a microfluidic device.133, 136, 141, 142 In one example, protein concentration in a
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microfluidic device was achieved using a nano-capillary array placed in a microfluidic
channel for concentrating large molecules in front of the array,141 and porous silica
membranes placed between adjacent microchannels that allowed buffer ions to pass but
excluded larger molecules.136 Nanoporous membranes in a microfluidic channel were also
used to achieve a molecular weight cutoff of protein molecules larger than 5700 Da.142 Ion
exclusion enrichment effects as a result of electrical double layer in PDMS/glass devices has
also been reported to pre-concentrate proteins.143 Another example employs a thermally
responsive polymer poly (N-isopropylacrylamide) (pNIPAm) film.144 This polymer has a
liquid critical solution temperature (LCST) and exhibits reversible wettability that can be
exploited to capture and release proteins from solution. The polymer film was coated in a
fluidic channel and a heater was used for rapid and controlled heating and cooling in small
volumes. Above the LCST, the film switches to a protein-adsorbing state that is more
hydrophobic, capturing proteins from solution; below the LCST, it switches to an
antifouling hydrophilic state, hence releasing the captured proteins.
Affinity-depletion methods have also been employed in microfluidic devices for
protein pre-concentration. In one example, affinity capture of lysozyme and albumin from
human cerebrospinal fluid was achieved in a microfluidic channel using UV
photopolymerization of glycidyl methacrylate and trimethylolpropane trimethacrylate that
was also derivatized with Cibacron-blue-3G-A, a triazine dye, known to have group
specificity for albumin and lysozyme.145, 146 In a similar example, a microfuidic channel with
immobilized metal affinity chromatography beads was used to enrich targeted
phopsphopeptides and allowed identification of trace proteins from human prostatic cancer
cell extracts.147 Integrated selective enrichment target
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148

fabricated on silicon have been

used for characterization of prostate-specific antigen from human seminal fluid co-isolated
by affinity chromatography.
1.9.1.3 Separation
LC has been demonstrated in microfluidic devices for peptide and protein
separations.149-156 In one example an array of methacrylate monolithic columns was prepared
in a microfluidic channel by UV-initiated polymerization to separate a peptide mixture from
trypsin digested proteins.149 In a separate approach a microfluidic device was used to
separate a digest obtained from the MCF7 breast cancer cell line. The cytosolic protein
extract was processed off-chip using a shotgun protocol, tryptic digestion and
prefractionation using strong cation exchange chromatography (SCX). The selected sample
subfractions were then separated in a microfluidic LC device using reverse-phase
chromatography.150 In a different approach, reverse-phase LC using a C-18 side chain
polymer monolith prepared in a microfluidic device was used to separate proteins and
peptides with resolution comparable to a conventional capillary HPLC column.151, 155 Multidimensional LC in microfluidic devices are still being investigated as a method for high
peak capacity for analyzing complex peptide mixtures in shotgun proteomics.
Electrophoretic separation of proteins and peptides has also been demonstrated in
microfluidic devices and reviewed by Lion et. al.157 Since the work described in this
dissertation employed electrophoresis, this technique will be discussed in detail. Capillary
electrophoresis concepts were first introduced in the early 80’s by Mikkers, Jorgenson and
co-workers.158 Compared to LC, CE is fast and achieves high separation efficiency with
nano-liter injection volumes.158, 159 There are various modes of CE, namely capillary zone
electrophoresis (CZE),158 micellar electrokinetic capillary chromatography (MEKC),160
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capillary gel electrophoresis (CGE),161 capillary isoelectric focusing (CIEF),162 and capillary
electrochromatography (CEC)163 which can be employed in protein separations. CZE is the
simplest form of CE where separations occur based on charge-to-size ratios. MEKC
employs micelles above their critical micelle concentration to act as mobile stationary phase
and modify sample mobility through hydrophobic interactions. The surfactants also serve to
minimize sample adsorption on to the capillary wall. CEC combines the principles of
electrokinetic pumping with high performance liquid chromatography. In CGE, separations
are based on size as they migrate through a gel matrix. The gel provides both static and
dynamic coating of the capillary wall suppressing the electro-osmotic flow to near-zero.
CIEF employs a pH gradient between the cathode and anode and hence samples focus at
their isoelectric point (pI) where net charge on the molecules is zero.
For the purpose of this dissertation, CZE will be discussed since it was the technique
used in this research. Capillary or microchip electrophoresis employs a voltage applied
across a capillary or channel to manipulate sample movements by exploiting their ability to
migrate in solution under a certain field strength. CZE is the simplest form of CE where
charged species are separated in a buffered solution based on charge-to-size ratio. Charged
molecules in solution inside a capillary/channel column exhibit differences in their
electrophoretic mobility (µ) due to their differences in size, charge (q) and frictional
coefficients (f), when a voltage, V, is applied.

μep =

q ν
=
f E

(1.1)

The migration velocity (ν) of analytes in solution is a function of their
electrophoretic mobility (µ) and the electric field strength (E).
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ν = μE

164

(1.2)

The electrophoretic mobility is an intrinsic property of the molecule and for
separation and hence resolution (R) between two species to occur, analytes must exhibit a
difference in mobility as shown in equation 1.3 below where N is the separation efficiency.

R=

1 Δμapp 1 2
N
4 μapp ,avg

(1.3)

The migration time (tm) along the capillary is determined by the equation;

tm

=

Lt Ld
L
=
μappV
μapp E

(1.4)

165, 166

where Ld is the capillary/channel length to the detector and Lt is the total capillary/channel
length. From equation 1.2, the migration velocity is affected by changes in the electric field
strength. However, increasing E results in an increase in current and therefore joule heating.
Typically, the current in CZE is directly proportional to the electric field strength, the square
of the capillary radius (r) and conductivity (κ) of the buffer used.

I ∼ Er 2κ

(1.5)
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From equation 1.5, it is clear that lower conductivity buffers and narrow inner
diameter capillaries/channels are required in order to increase the analyte migration velocity
without excessive joule heating. Normally, capillaries/channels of 25 to 100 µm internal
diameter are used in CZE to allow application of high field strengths while maintaining low
current. While for microchips, the channel properties will depend on the material used for its
fabrication, capillaries employed in CZE are mostly made from fused silica which consists

33

of silanol functional groups on the inner wall surface. The silanol groups ionize in the
presence of appropriate buffer pH, typically above their pKa. At pH greater than 5, the
capillary wall bears a negative charge and results in an increase in surface charge density.
Upon application of a voltage, current flows through the capillary and an electric potential
arises due to positively charged buffer ions aligned near the capillary wall. This potential is
referred to as the zeta potential (ζ). The zeta potential causes a resistance to bulk flow of
solution, a phenomena called electroosmotic force (EOF) as shown in equation 1.6, where, ε
is the permittivity (dielectric constant) of the buffer solution, ζ is the zeta potential and η is
the buffer viscosity.

μeof =

ες
4πη

(1.6)

The velocity of this bulk solution flow is computed from the equation below.

ν EO = εζ E η

(1.7)
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The magnitude of the EOF is also dependent of the ionic strength of the buffer
through its effects on the zeta potential. In bare fused capillaries, the direction of the EOF is
usually from the anode to the cathode since the wall is negatively charged as shown in
Figure 1.10. At the same time, positively charged species move towards the cathode while
negatively charged species migrate towards the anode. Usually if the magnitude of the EOF
is greater than the electrophoretic mobility of the negatively charged species, the apparent
mobility of negatively charged species is towards the cathode. However, in cases where the
magnitude of the electrophoretic mobility of the negatively charged ions is greater than that
of EOF, these ions are never detected by detectors placed towards the cathode side. Neutral
molecules are swept by the magnitude and velocity vector of the EOF towards the cathode.
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For charged analytes, the apparent electrophoretic mobility (µapp) is therefore determined by
the magnitude of their individual electrophoretic mobility (µ) and velocity of the
electroosmotic force (νEO) as expressed in equation 1.8.

μapp = μep ± μeof

(1.8)
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Figure 1.10 A schematic illustrating the migration of ions inside a capillary upon
application of an electric field. Positive and negative ions move towards the negative and
positive electrodes respectively.
Full characterization of peak profiles typical of a CZE separation requires a
description of the concentration distribution of a solute as a function of position and time
within the capillary. The average position of a zone or band is determined by the net
migration time, while the concentration distribution or profile is governed by diffusion and
other dispersive parameters. The average position or migration time t is expressed as a
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function of the total length migrated by the zone L, apparent mobility µapp, and the applied
electric field E.

t= L

(1.9)

μapp E

165, 166

The efficiency of Gaussian-shaped CZE peaks is measured by theoretical plates N or
the height of a theoretical plate H. Normally H is defined as
H=

L σ T2
=
N
L

(1.10)

165

where σ2total accounts for all the dispersive parameters. As a sample zone/band migrates
along the capillary, it undergoes band broadening (zone dispersion) mainly due to
longitudinal diffusion, σ2diff.168 This dispersion is inevitable in CZE due to the concentration
gradient along the direction of the electric field. However, other factors can contribute to the
total peak dispersion such as joule heating, σ2joule.169 This affects the electrophoretic
mobility due to the parabolic temperature profile and hence parabolic velocity profile across
the capillary. The length of the finite injection volume σ2inj, as well as finite detection
volume σ2det affects zone dispersion. Long injection plugs or long detector cells contribute
more to zone dispersion. Other factors include solute-wall adsorption, σ2ads,170 concentration
overload, σ2conc in cases where the analyte ion concentration is higher than that of buffer
ions,171 and also coiling or turns

172, 173

introduced to the separation capillary and extra

column effects, σ2etx.col.168, 174, 175 These factors are assumed to be independent and the total
dispersion is therefore expressed as a summation of the individual second moments of the
concentration profile, the variance (σ2total).
2
2
2
2
2
2
2
2
σ total
= σ diff
+ σ Joule
+ σ inj
+ σ ext
.col + σ coil + σ ads + σ conc
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(1.11)
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Recently, microfluidic devices have been used to demonstrate two-dimensional
separation of proteins and peptides.176-180 In one example, MEKC was employed in the first
dimension followed by CZE for peptide separations. This device produced a peak capacity
of 4200 (110 in the first dimension and 38 in the second dimension) and was used to identify
a peptide from a tryptic digest of ovalbumin and to distinguish between tryptic digests of
human and bovine hemoglobin.176 Two-dimensional separation of proteins has also been
reported. In one example, IEF was coupled to CZE separations.178 In a different example, a
combination of IEF and SDS PAGE was demonstrated to achieve a peak capacity of
1700.177 Another example reported a peak capacity of 1000 using sodium dodecyl sulfate
microcapillary gel electrophoresis (SDS µ-CGE) in the first dimension and MEKC in the
second dimension.179
1.9.2

Microfluidic Systems for Integrated Protein Sample Processing

Microfluidic systems or (micro-total analysis systems, µ-TAS) are integrated sample
processing platforms assembled by integrating several modular microfluidic devices as
analysis components in a fashion similar to how integrated circuits for electronics are
fabricated.118-120 The planar substrates used in fabricating microfluidic devices are being
exploited for integration, miniaturization, multiplexing, high throughput and automation of
sample processing steps used in protein analysis to accelerate biomarker and drug
discovery.118-120,

181

Whereas integration of processing steps circumvents sample losses,

contaminations and false positives or negatives arising from transfer steps,116,

128, 182

miniaturization affords the assembly of modular devices that offer potentially portable and
disposable diagnostic platforms that can be used for point-of-care testing.117-120 On the other
hand, high throughput assays can be used for large scale screening that can be automated to
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reduce the turnaround time for biomarker discovery, clinical diagnostics and also to improve
the accuracy of results.183 Further, the ability to perform multiplex assays on µTAS devices
reduces the cost of clinical diagnostics, research and development and allows assay controls
to be run with every sample processing step.184
There have been no attempts reported to date that address the integration of entire
sample processing steps such as whole cell lyses, protein extraction or isolation, enrichment,
gel separation, proteolytic digestion and chromatographic separations onto a single
microfluidic device. Hence, there exist no systems that can process protein samples in a
single automated platform. However, a few efforts have been directed towards the
integration of selected processing steps. Examples of integrated systems reported in the
literature include devices for proteolytic digestion of protein mixtures followed by
subsequent electrophoretic separation of the generated peptide fragments.185-187 In one
example, a system was described where a model protein, oxidized insulin B-chain, was
enzymatically digested in a heated channel and the resulting peptides electrophoretically
separated. The peptides were thereafter labeled with a fluorophore in the same device for
fluorescence detection. This system is shown in Figure 1.11.187
Another report of an integrated system addressed the integration of solid-phase
extraction of proteins followed by

proteolytic digestions,188 or digestion of proteins

followed by phosphopeptide enrichment.189 An example of a microfluidic system used for
enzymatic digestion of a protein followed by enrichment of generated phosphopeptides from
the digest with IMAC is shown in Figure 1.12. The first portion of the channel was the
digestion zone while the downstream portion of the channel was used for IMAC capture of
the phosphopeptides. There have also been systems focused on solid-phase extraction and
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concentration of peptides followed by a downstream electrophoretic or chromatographic
separation of the enriched peptides.134, 152, 190-192 An integrated microfluidic system has also
been described for protein pre-concentration using a porous silica membrane in a fluidic
junction that allowed buffer ions to pass but excluded proteins, which were later injected
into the separation channel for electrophoretic separation.136 A schematic of this system is
shown in Figure 1.13.

Figure 1.11 A microfluidic system used for on-chip proteolytic digestion of proteins,
separations and post column labeling of peptide fragments, (Reproduced from J.
Chromatography B 745 (2000) 243 –249).
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Figure 1.12. A microfluidic system used to integrate trypsin digestion of proteins and
selective affinity capture of the generated phosphopeptides, (Reproduced from Analytica
Chimica Acta 564 (2006) 116–122).

Figure 1.13 A microfluidic system used for protein pre-concentration with porous silica
membrane and electrophoretic separation of the pre-concentrated proteins, (Reproduced
from Anal. Chem. 2005, 77, 57-63. Copyright, 2005 American Chemical Society).
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Recently a device has been reported that integrates separation of proteins with
downstream proteolytic cleavage of the separated proteins.193 Using this system, myoglobin
was isolated from bovine serum albumin using integrated valves and then selected for
enzymatic digestion in a rotary micromixer. The peptide fragments were later recovered and
used for protein identification. A sketch of the system is shown in Figure 1.14.

Figure 1.14 A sketch of an integrated microfluidic system comprised of injection/separation
module, protein trapping module, a circular micromixer and an enzyme activation module.
The system actuation and pumping is achieved using electro-osmotic driven flow and was
used to separate proteins followed by digestion of the isolated proteins. (Reproduced from
The Analyst, 2006, 131 (10), 1122 – 1128. Copyright 2006, Royal Society of Chemistry).

1.10

Protein Identification
Mass spectrometry (MS) has become one of the most widely used analytical tools for

protein identification.194, 195 MS is an analytical tool used for measuring the mass-to-charge
ratio of both individual atoms and molecules or fragments from intact molecules in order to
deduce structure. MS is a separation technique that separates ions in the gaseous phase. MS
enables protein characterization and de novo amino acid sequencing by mass measurements
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that provide identity, sequence and structural information without inference to protein
databases.52, 196, 197 This information can also be used to determine the type and location of
protein modifications.198, 199 The identity of a protein can also be determined using peptide
mass mapping by performing searches on available protein databases.21, 200 The peptides are
generated from proteolytic digestion of proteins using “shotgun” or “bottom-up” protocols.
Another protein identification approach employs sub-sequence of a transcribed proteincoding or non-protein-coding nucleotide sequence by searching expressed sequence tag
databases. Proteins can also be identified using “top-down” approaches by subjecting intact
protein ions and large protein fragments directly to tandem mass spectrometry in a Fourier
transform mass spectrometer.
Protein quantification can be accomplished using a number of MS approaches that
allow direct correlation of the relative amounts of analyte present in a given sample to the
MS ion intensity signal and by using stable isotope tagging.201-207 However, there exists an
enormous difference in physical properties and protein abundances or concentration in most
proteomes in the order of 106 to 109.37 For example in serum, albumin, which is the most
abundant plasma protein occurs at a concentration of approximately 50 mg/ml. On the other
hand, cytokeratins commonly used tumor markers, although abundant in epithelial cells and
carcinomas are nevertheless in low abundance (~ 10 to 50 ng/ml) in patient blood.37,
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Although MS is capable of routine femtomolar limits of detection, the nanomolar
concentration typical of tumor makers in serum is a challenge in the presence of abundant
proteins. The difference in protein concentration is usually higher than the dynamic range of
~ 104 for most MS.208,

209

In addition, ionization of low abundant peptides is often

suppressed and their spectra are masked by high abundant species.210 Therefore, sequential
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analytical processing steps are the key to simplification of sample complexity in order to
improve sensitivity and limits of detection for MS analysis.
Integration of microfluidic devices to biological mass spectrometry is a logical step
toward developing automated platforms for high throughput processing of biologically
complex samples available in limited amounts or in relatively low concentrations.211-213
Chemical and biochemical analyses often probe qualitative, structural and quantitative
information and many efforts still continue to progress towards realizing the full potential of
these devices by integration with existing analytical detectors.211,

214-217

A long-term

challenge lies in scaling-down most of the traditional analytical techniques into miniaturized
platforms without compromising their superb performance. This dissertation focuses on the
coupling of integrated sample processing systems to biological mass spectrometry. In
particular, the proteolytic cleavage of proteins in micro-reactors followed by the separation
of the resultant peptides with on-line MS detection will be discussed in detail.
1.10.1 Basics of Mass Spectrometry
A typical mass spectrometer (MS) consists of a sample inlet, an ionization chamber
and source, a mass analyzer and a detector. In the ionization chamber, analyte molecules are
converted into gaseous ions using various ionization methods, the ions are then accelerated
into a field free region called a mass analyzer. A mass analyzer, which in most cases is
under high vacuum, separates the ions in the gaseous phase based on their mass-to-charge
(m/z) ratio. The separated ions are then detected using a suitable sensing element and the
current arising from these ions is digitized to form a mass spectrum. Mass spectrometers are
credited for their unsurpassed accurate mass measurements that provide molecular
specificity and identification capabilities. Figure 1.15 shows a block diagram of the
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individual components; sample inlet, ionization chamber, mass analyzer, detector data
acquisition and a vacuum system that constitute a MS.

Figure 1.15 A block diagram of a mass spectrometer consisting of a sample inlet, ionization
chamber, mass analyzer, vacuum pump, detector and data acquisition modules.
1.10.2 History of Mass Spectrometry
In 1897, Joseph J. Thomson gave a lecture at the Royal Institute about observations
on the existence and properties of canal rays (positive ions).218-220 Earlier, Eugene
Goldestein had demonstrated that the presence of gases in cathode ray tubes gave rise to rays
that behaved differently from cathode rays. In 1898, Wilhelm Wein deflected these rays in
the opposite direction of cathode rays using electric and magnetic fields and concluded that
they were positive. Thomson improved on Wein’s data and their work formed the
foundation of mass spectrometry in subsequent measurements of masses of ions in gases at
low pressures.221 However, it was not until two decades later that an application for
Thomson’s experiments was developed by Francis W. Aston and Arthur Jeffrey Dempster to
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discover new isotopes, their relative abundances and exact masses.222, 223 Since then, MS has
undergone extensive innovations driven by a wide range of applications. Most MS
applications were driven by the petroleum industry and uranium isotope separation in the
1940’s.224-226 The improvements in high resolution MS and exact mass measurements
extended the applications to organic chemistry in the 1950’s through the 70’s.227 All along,
MS application to biological fields was limited by lack of suitable soft ionization techniques
for large biological molecules. The discoveries of plasma desorption,228 fast-atom
bombardment (FAB)229 electrospray ionization (ESI)230,

231

and matrix assisted laser

desorption/ ionization (MALDI)232 extended the upper mass range of MS allowing analysis
of large biopolymers with MW over 100 kDa. These developments coupled to other
innovative developments in mass analyzer technology have elevated MS to an indispensable
technique in biomedical research, and brought about a new field known today as biological
mass spectrometry.30, 233 Today, MS is the primary technique used in the identification of
proteins.
1.10.3 Types of Mass Spectrometers
Mass spectrometers differ mostly depending on the type of ionization technique or
the type of mass analyzer employed. The mass analyzer and ionization technique in any
given mass spectrometer is governed by the intended application. In this dissertation, only
the time-of-flight (TOF) mass analyzer will be discussed in detail. Further for ionization
techniques, only MALDI and ESI, the commonly used and dominant ionization techniques
employed for a variety of biological molecules ranging from medium to fairly large polar
molecules, will be discussed. A detailed discussion on different types of mass analyzers and
other ionization techniques can be found in a standard mass spectrometry textbook.
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1.10.3.1 Ionization Techniques
Ionization techniques can be classified as either soft or hard ionization depending on
the type of ions generated. Hard ionization techniques are generally characterized by
extensive fragmentation while soft ionization techniques yield mostly intact ions. Examples
of hard ionization techniques includes electron ionization,234 chemical ionization,235-237
atmospheric pressure chemical ionization, thermospray,238-240 field desorption,241 and laser
desorption ionization.242,
desorption,

244

243

Example of soft ionization techniques includes; plasma

electrospray ionization which uses a voltage bias at the tip of a capillary

probe to exert an electrostatic force on liquid flowing through the capillary as shown in
Figure 1.16.245 The liquid therefore emerges from the exit of the capillary as a “Taylor cone”
jet of fine droplets which undergo further disintegration and evaporation to form multiply
charged ion species.231 Atmospheric pressure chemical ionization is similar to ESI, however
it employs a corona-discharge needle at the end of a metal capillary to create a plasma that
allows proton transfer reactions and a lesser extent of fragmentation to occur.246

Figure 1.16 The ionization process in ESI; voltage application at the tip of a capillary forms
charged droplets, which undergo evaporation and division as they shrink in size due to
charge repulsion resulting in multiply charged ions that are accelerated to a mass analyzer.
46

Another type of soft ionization technique is MALDI, which employs a focused
pulsed laser beam to deposit energy into an excess of matrix host molecules for desorption
and ionization of the analyte guest molecules in the gas phase as depicted in Figure 1.17.247
Most commonly used MALDI matrices are acidic molecules that are used in excess of the
analyte molecules to absorb the laser energy. Initial studies with laser desorption employed
direct irradiation of sample with a laser beam without the use a matrix, an approach
commonly referred to as laser desorption ionization (LDI).242,

243

In LDI, the extent of

energy transfer that leads to thermal degradation is difficult to control. Further, analyte
compounds exhibit selective absorption of radiation at different laser wavelengths. These
limitations led to the development of MALDI in 1985. One effort led by Karas and
Hillenkamp

232

and coworkers

used tryptophan as a matrix with a 266 nm laser. Two years later, Tanaka
248

mixed their sample with a slurry of 10 nm finely divided cobalt particles

in glycerol with a 337 nm laser and was able to form ions from intact proteins. The mixing
of sample with an appropriate matrix and use of appropriate laser wavelength was critical to
the success of MALDI. Typically, guest analyte molecules are mixed with an excess of host
matrix molecules, which absorbs irradiation energy at the laser wavelength and transfers the
energy to the sample in a controlled manner. The ionization is considered to be soft because
no extensive fragmentation of analyte molecules is observed. Singly charged species are
typical of the MALDI process and results in the formation of both positive and negative
ions. In some cases, double or triply charged protonated ions are formed in low abundance.
The mechanism of MALDI is not well understood, one popular theory postulates that the
desorption of sample and matrix into a gas-phase plume may result in ionization through
gas-phase proton transfer reactions.249
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1.10.3.2 Mass Analyzers
For most mass spectrometers, the mass analyzer is the heart of a MS where ions are
separated based on the ratio of the mass to charge (m/z). For TOF, a nominally
monoenergetic beam of ions enters the mass analyzer and ion transmission based on velocity
occurs as mass resolved ions arrive at the detector. The Figures of merit for a typical mass
analyzer comprises the mass range, resolution, scan speed and detection sensitivity.

Figure 1.17 A schematic of the MALDI process with a linear time-of- flight mass analyzer.
Focused UV or IR laser is used for desorption and ionization of sample mixed with a matrix
resulting in the formation of singly charged ion.
Time-of-flight (TOF) mass analyzers employ differences in velocity to separate ions
in the gas phase.250, 251 Ions drift in a field free region inside a flight tube after acceleration
to a constant kinetic energy, Ekinetic given by the equation:
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Ekinetic =

1 2
mν
2

(1.12)

250

The initial kinetic energy of ions is dependent on their acceleration voltage V and the ion
charge z.

Ekinetic = zV =

1 2
mν
2

(1.13)

250

Rearranging equation 1.10 shows that the ion velocities are an inverse function of the square
root of their m/z values:

ν = 2zV m

(1.14)

250

The actual time-of-flight is a summation of the time ions spend in the ion source, flight tube
and any post-acceleration at the detector. However, for most configurations, the flight tube
distance and therefore an ion’s flight tube time is very large compared to the time spent in
the ion source. The approximate time-of-flight for an ion (in the 100 µs time frame for
typical conditions) in a flight tube of length L, is estimated by the equation below;
t=

L

ν

=L m

(1.15)

2 zV

250, 252

The mass resolving power between any two ions of mass m with a discernable mass
difference of Δm is given the equation;
R=

m
t
=
Δm 2Δt

(1.16)

250

Traversing ion velocities are an inverse function of the square root of their m/z values.
Therefore, light ions travel faster and have shorter flight times to reach the detector
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compared to the heavy ones. The time-based spectrum is converted to a mass spectrum by
measuring the flight times of two different ions (a, b) of known masses.

m = at

1

2

+b

(1.17)

Pulsed ionization or pulsed acceleration potentials in case of a continuous ion beam,
allows ions to enter the flight tube at the same time as discrete ion packets, fulfilling the
primary requirement of TOF analyzers. The high ion transmission efficiency
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and fast

data acquisition rates for TOF mass analyzers allow complete mass spectra to be recorded in
microsecond time intervals. Ion detection after separation by a mass analyzer is
accomplished using electron multipliers such as microchannel plate or photomultipliers that
require ion-to-photon conversion after ions first strike a scintillation material to emit
photons.
1.11

A New Microfluidic System for Processing Protein Samples

We are developing a novel microfluidic system for integrated sample processing of
proteins that can be interfaced to a variety of different biological mass spectrometers (MS),
such as MALDI or ESI. The system is comprised of a protein extraction and preconcentration unit in series with a fluidic network for performing two-dimensional
separations of extracted proteins. After the two-dimensional protein separation unit is
another unit consisting of a series of solid phase micro-reactors arrayed orthogonally to the
second dimension fluidic channel for proteolytic cleavage of individual components selected
from the components eluting in the second dimension separation channel. The reactors are
connected to a downstream separation unit for sorting peptide fragments that finally feed the
separated peptide fragments to a mass spectrometer for protein identification. A schematic
diagram for the integrated sample processing device is shown in Figure 1.18.

50

The system input is whole cells that are lysed and the protein components isolated
from the cellular matrix using nanopillars decorated with thermally-responsive polymers.
Extracted proteins are pre-concentrated using a thermally responsive polymer such as poly
(N-isopropylacrylamide) (pNIPAAm). This polymer exhibits reversible wettability and
protein adsorption properties that can be exploited to capture and release proteins. Above the
liquid critical solution temperature (LCST), the polymer is hydrophobic and below the
LCST, the polymer is extremely hydrophilic, therefore acting as an on-off switch to preconcentrate extracted protein in the channel.

Figure 1.18 A schematic diagram illustrating an integrated sample processing system for
protein analysis. The system is comprised of a protein pre-concentration module, twodimensional protein separation module, solid-phase micro-reactors for digestion of separated
proteins, and peptide separation module connected to a MS.
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Extracted proteins are then injected into the two-dimensional separation unit for
separation. In this unit, SDS PAGE and MEKC are used to separate protein mixtures. Two
conductivity detectors are used to monitor separations in this unit. Protein bands eluting
from the second dimension are injected to individual solid phase micro-reactor for digestion.
The solid phase micro-reactors consist of trypsin immobilized on high surface area
nanopillars for rapid digestion. Peptide fragments generated from these nano-reactors are
further separated downstream using microchip electro-chromatography or free solution
electrophoresis. The peptide fragments are recovered and detected using MALDI MS and
thereafter the proteins are identified using peptide mass fingerprinting.
This dissertation will cover the proteolytic microfluidic reactors module, peptide
fragment separation module and the interfacing module to on-line MALDI MS using a
rotating ball inlet described above. Chapter 2 describes a rotating ball inlet for interfacing
on-line MALDI MS to microfludic devices. In Chapter 3, a detailed discussion of the
peptide separation module is outlined. Chapter 4 covers the proteolytic digestion of proteins
in microfludic reactors and Chapter 5 describes future work towards integrating the modules
to a fully functional proteomics microfluidic system.
1.12
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CHAPTER 2. ROTATING BALL INLET FOR ON-LINE MALDI TOF MS
Most MALDI TOF MS instruments are designed for off-line sample introduction,
which requires ion source vacuum break to allow the transfer of samples into the ionization
chamber for analysis. This step often can result in sample losses, increased sample
processing time and can create operational difficulties due to manual intervention into the
processing pipeline.1-3 Modification of a MALDI TOF MS ion source is required to allow
on-line transfer of liquid samples from a microfluidic device into the essentially high
vacuum and solid sample MALDI MS technique.4-9 On-line MALDI MS analyses are
desired to increase sample throughput, for automation of sample preparation and to provide
the ability to acquire real-time data. On-line MALDI MS also allows easy switching from
one sample to another without having to break the ion source vacuum and thereby reducing
instrument downtime.10-12 Discussed here are approaches for analyzing samples from a
microfluidics device using MALDI MS.
2.1

MALDI MS Analysis From a Microfluidic Device

The developments of matrix assisted laser desorption and ionization mass spectrometry
(MALDI MS) for on-line and off-line analysis from microfluidic devices stems from a
number of facts. The low sample volumes typical of analyses in a microfluidic device are
readily compatible with low sample consumption in MALDI MS.13,

14

Further, sample

preparation often involves a series of steps to address sample complexity and microfluidic
devices are attractive platforms for integrated sample processing prior to MALDI MS
analysis. The fast response and data acquisition rates with MALDI TOF MS readout allows
for integration with rapid analysis in microfluidic devices. MALDI MS provides high
resolution and precise mass measurements that generate high molecular specificity and
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identification capabilities. These Figures of merit coupled with the sensitivity and high mass
range makes MALDI MS a versatile detector and increases the scope of microfluidic assays.
2.1.1

Off-line Analysis

Off-line analysis from a microfluidic device is rather straightforward. Common
approaches entail either fraction collection from a microfluidic device and spotting them
onto a MALDI sample plate or placing the entire device inside a MALDI MS ionization
chamber for analysis.15 In the first approach, bottlenecks are often encountered in the
deposition technique when sampling low volumes.16 However, automation of the deposition
step can increase the throughput of this off-line approach.17,

18

In one example, a piezo-

electric microdispenser was used to automate the sample deposition into micro-vials before
MALDI MS analysis.17

The second approach entails sample processing on an open

substrate or in enclosed fluidic network then removing the cover plate of a microfluidic
device before analysis with MALDI MS. Usually, no sample transfer steps are involved with
this approach hence limiting sample losses. Limitations with this off-line approach are
encountered when the size of the device cannot be fitted into the ionization chamber to be
addressed with MALDI MS readout. In such cases, the device is split into smaller
addressable sizes,19 or if the device is of required size, slight modifications are made on the
sample target to allow MALDI MS readout.15, 20 When the cover of a microfluidic device
has to be peeled off after sample processing, caution is required to preserve the integrity of
the sample.21
2.1.1.1 Off-Line MALDI Interfaces
Off-line MALDI analysis from microfluidic devices may be automated using various
interfaces. In one approach, a impulse-driven momentum transfer droplet deposition
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22

or a

heated droplet interface employed a transfer tube manipulated by a robotic arm which was
mounted on an x-y-z translation stage to transfer samples from a liquid chromatography
separation platform to a MALDI target.23 In a similar development, a deposition system
based on non-contact pulsed electric field 24 was demonstrated to transfer the effluents from
multiple microfluidic channels directly onto MALDI targets.25 A continuous contact
deposition using a capillary dragged on a matrix-precoated membrane target was also
developed to combine capillary electrophoresis to MALDI MS.26 Recently, a system based
on discrete nanoliter droplet plugs as microreactors for performing solution reactions in
microfluidic with off-line MALDI MS detection was reported.27
Off-line analysis can also be accomplished by placing an entire device inside the
ionization chamber.19, 21, 28 Gustafsson et.al19 described a microfluidic device in a compact
disk format that employed centrifugal force to control movement of liquids within the
device. Sample applied into the microfluidic device was washed and eluted through a 10nL
reversed-phase column followed by downstream co-crystallization with MALDI matrix in
the desorption area located at the outlet port. In a somewhat similar off-line approach,
electrowetting-on dielectric (EWOD) was demonstrated for MALDI sample preparation and
purification in a microfluidic device.18,

29

Liquid droplets of sample and matrix were

digitally moved to specific locations using EWOD array of electrodes patterned on a
substrate material for electrical contacts.
In another example, sample processing was carried inside an enclosed microfluidic
device; the cover of the device was then peeled off, no matrix was required before loading
the entire device inside the vacuum for interrogation with an IR laser.21 Briefly, a
PMMA/PDMS hybrid device was used to perform SDS-polyacrylamide gel electrophoresis
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in an enclosed fluidic channel. The PDMS cover used to enclose the fluidic channel was
carefully removed in order to access the gel-line. No matrix addition step was required since
compounds present in the cross-linked gel served as matrix for IR-laser desorption
ionization. The laser was either scanned across the channel while the device was stationary
under high vacuum or the device was moved across the path of a focused laser line inside
the ionization chamber.
2.1.2

On-line MALDI Interfaces

On-line analyses are highly desired for their high sample throughput, automation and
ability to acquire real-time data while experiments progress. A number of attempts for online sample introduction into a MALDI MS have been reported in literature and are briefly
mentioned below.
2.1.2.1 Continuous Flow (CF) MALDI
Continuous flow MALDI employs a capillary to deliver samples premixed with a
matrix to a metal porous frit embedded in a sample stage.30-32 The CF porous probe allows
liquid samples to be introduced into a MALDI ionization source at controlled flow rates.
The CF probe approach has had limited success due to water freezing and clogging of liquid
matrices commonly used in UV-MALDI which block the pores of the metal frit at the
capillary end leading into vacuum.8 Developments in IR-MALDI indicate that strong
material ablation associated with IR lasers may alleviate freezing problems if protic solvents
serve as matrix.31 Adapting the CF probe for microfluidic is not practical because it requires
connecting a capillary to the microfluidic device, placing a metal frit on top of a fluidic
channel or fabrication the frit at the end of a fluidic channel. This approach results in
wasteful sample consumption, material mismatch, extra-column and large dead volume
effects from capillary interconnect.
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2.1.2.2 Vacuum Draw Interface
In this approach, the MS vacuum is used to induce a self activated pressure-driven
pumping mechanism as a driving force to initiate liquid flow inside a microfluidic device.33
Briefly, a device carefully filled with reagents in the reservoirs is mounted onto a standard
MALDI sample target. The MS vacuum thereafter used to induce a pressure driven flow of
the reagent towards an exit reservoir where products formed in the device are detected. The
device was recently modified to include a sub-micron hole on the device cover to desorb
effluents as the flow along the fluidic channel.34
2.1.2.3 Aerosol MALDI
Aerosol MALDI involves generation of aerosol particles at atmospheric pressure
using pneumatic, ultrasonic, thermal or electrostatic potential means. The particles are then
introduced into a mass analyzer through a differentially pumped capillary inlet.35 A matrix is
usually added to the aerosol particles before entering the mass spectrometer or sample is
premixed with a proper matrix before spraying.36 Aerosols have a rapid solvent evaporation,
which minimizes the incompatibility of liquid introduction into the high vacuum of a mass
spectrometer; however it is uneconomical with sample. A pulsed UV laser is used to form
ions from the aerosol particles. The aerosol interface is limited in mass range and resolution
due to particle transmission efficiency.8
2.1.2.4 Vacuum Deposition
On-line MALDI has also been demonstrated with a vacuum deposition approach. A
fused silica capillary is used to deliver liquid samples and matrix to a rotating wheel placed
inside the ion source of a mass spectrometer.10 The capillary is in contact with the wheel to
minimize clogging at the exit. By rotating the wheel, a narrow sample trace deposit is
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transported into the desorption region of the mass spectrometer. A major draw back of the
approach is limited operation time that requires retrieving the wheel from vacuum after one
complete rotation. In a recent development the wheel was substituted with a disposable
Mylar tape to increase the operation time and for sample archiving.11, 12
2.1.2.5 Atmospheric Pressure (AP) MALDI
AP MALDI alleviates the vacuum requirements for operating the MS ion source.
Ionization is performed with a laser at atmospheric pressure and the ions generated are
guided into the vacuum of the mass spectrometer electrostatically or using a carrier gas.37-39
Normally, a quadrupole ion guide is required between the AP MALDI source and the
vacuum to collimate the ions into the mass analyzer. The AP MALDI source when
combined with the appropriate mass analyzer has the potential to couple high throughput
analyses in microfluidic devices.
2.1.2.6 Rotating Ball Inlet
As mentioned previously, on-line analysis from a microfluidic device require
specially tailored interface for coupling the device to allow sample transfer from the fluidic
channels into the ionization chamber of the MS. One approach already reported in literature
employs a rotating ball inlet for on-line sample transfers from microfluidic devices into an
ionization chamber of a MALDI MS.40 Although the rotating ball inlet was originally
developed for continuous sampling of volatile species,41,

42

further modifications have

allowed for coupling of micro-scale separation to on-line MALDI MS.43-45 Briefly, the
interface consists of a 0.75″ stainless steel ball fitted with a drive shaft and was mounted on
an ISO-100 flange. The drive shaft was attached to a motor on the other end to facilitate
rotation of the ball. This ion source configuration allowed the rotating ball inlet to be
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mounted entirely at atmospheric pressure with a small portion of ball exposed through a
gasket seal to the ion source vacuum. The rotating ball served as a mechanical transport
mechanism that introduced samples deposited on its surface past the gasket into the
ionization chamber. To eliminate sample cross-talk, a cleaning system made from a solvent
saturated felt pad was mounted on-line for surface regeneration. A clean surface was always
presented for subsequent deposits after the previous deposition region passed out of the
ionization chamber, thereby making this inlet self replenishing. A schematic representation
of the interface coupled to a microfluidic device for on-line analyses is shown in Figure 2.1.

Figure 2.1 Schematic representation of a rotating ball inlet; (A) stainless steel ball (B) drive
shaft (C) gasket (D) ISO-100 flange (E) ion extraction grid (F) matrix syringe pump (G)
Cleaning solvent pump (H) microfluidic chip (I) separation channel (J) reservoirs (K)
cleaning system (L) waste solvent drain.

2.1.3

Off-line Versus On-line Analysis

Generally, off-line and on-line analysis approaches from microfluidic devices are
complementary. Despite the strengths and weakness associated with either approach, a
comparison can be made with regard to performance, ease of implementation and the
robustness of the approach. Off-line approaches are performed without major modifications
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of either the microfluidic device or the mass spectrometer and the systems performance is
not significantly affected. However, in some approaches, during readout time, the laser or
device is moved and depending on the modifications done on the ion source; the mass
spectrometer performance can be affected. Mass resolution is often compromised in cases
where the ions focusing field is affected by device movements and position within the ion
source. Careful consideration of these issues during design and modification of the ion
source can tremendously reduce the effects on mass resolution. Some off-line approaches
generally suffer from sample losses associated with sample transfer steps and limited sample
throughput. However, sample losses arising from sample transfer steps can be avoided by
the direct analysis of samples within the microfluidic device. On the other hand, on-line
approaches like rotating ball inlet require major adjustments on a typical MALDI MS ion
source that can affect mass resolution and sensitivity. On-line analysis reduce instrument
down time and have a high sample throughput compared to off-line approach. Modifications
required for a typical MALDI MS ion source for on-line analysis are demanding and
difficult to optimize but avails the instrument to various front-end sample processing
techniques.
2.2

Experimental Section

2.2.1

Ball Inlet

To integrate microfludic platforms to on-line MALDI TOF MS, an interface based
on a rotating ball inlet was developed with a configuration that allowed on-line transfer of
sample and matrix from atmospheric pressure into the high vacuum of a MS ionization
chamber. The interface was made from type 316 stainless steel ball of 19 mm (0.75 in.) in
diameter that were obtained from (Small parts, Miami Lakes, FL). A 6 mm hole (0.25 in.)
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was drilled through the center of the ball and a stainless steel drive shaft of same diameter
was press-fit into the hole. The ball assembly was mounted on a modified stainless steel
ISO-100 flange, which had a 15 mm circular hole machined to a thickness of 3 mm oncenter. A circular Teflon gasket with a 9 mm central hole was specially designed and
machined to fit between the ball and an ISO-100 flange face. Vacuum grease was applied
between the gasket and the flange before the gasket was sandwiched between the ball and
the flange to form a vacuum seal. The ball was held in place by two stainless steel blocks
with sintered bronze bearings press fit to allow free rotation of the shaft. The stainless steel
bearing blocks were held against the ISO-100 flange by four adjustment screws. The
majority of the ball was at atmospheric pressure and exposing only a small portion of the
ball to the vacuum. Centering the ball on the shaft was critical, since slight wobble in the
shaft caused a vacuum breach as the ball rotated. The ball-gasket seal was sufficiently
vacuum-tight to maintain a pressure of 10-5 Torr or lower when methanol solvent was
applied to the air-side of the ball.
The ISO-100 flange with the ball assembly were mounted on an 8 in.-diameter 25
mm-thick Delrin (acetyl resin) insulator flange that allowed the entire ball assembly to be
raised to the mass spectrometer acceleration voltage while the remainder of the mass
spectrometer remains at ground potential. During operation, the rotating ball and ISO-100
flange assembly were held at 10 kV, and an acceleration grid 13 mm from the flange surface
was held at ground potential. Rotation of the ball was accomplished using a multi-speed
transmission motor scavenged from a withdrawal and infusion syringe pump (Model 901,
Harvard Apparatus, Holliston, MA). Further rotational control was achieved by connecting
the motor to a variable AC transformer for fine speed adjustment on each particular gear. A

74

digital image of a rotating ball interface with the assembly mounted on an ISO flange is
shown in Figure 2.2.

Figure 2.2 A digital image of the entire rotating ball inlet assembly mounted onto an ISO100 flange, the drive shaft and the ball inlet are marked with yellow arrows, the gasket seal
is seen as a white mark behind the ball position. The drive shaft and the ball are rotated
clockwise facilitating sample transports into the ionization chamber of the MALDI MS.

2.2.2

MALDI TOF Mass Spectrometer

The ion source chamber was modified so that the desorption and ionization laser
could be directed at the center of the rotating ball flange through a quartz window at a 45°
angle with respect to the flange. A video camera and macroscopic lens was directed through
a second port on the opposite side of the chamber and was used to view the ball in operation.
A 355-nm Nd:YAG laser (Minilite, Continuum, Santa Clara, CA) was used for the MALDI
experiment. The laser repetition rate was set at 10 Hz, and the laser energy was attenuated
with a polarizer to ~ 10-15 µJ for desorption. The laser was focused to a spot size of 100 x
300 µm measured using laser burn paper. The ion source was evacuated using a 1500 L/s 6in. diffusion pump (M-6, Varian, Lexington, MA), and the flight tube was evacuated using a
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345 L/s turbomolecular pump (Turbovac 360, Leybold, Export, PA). A 25-mm aperture
separated the flight tube from the ion source. During operation, the ion source operated at a
pressure of 3 x 10-6 Torr, and the flight tube, at a pressure of 2 x 10-7 Torr. A was used. A 18
mm bipolar ion-to-photon conversion detector and a standard microchannel plate detector
(Burle, Sturbridge, MA) were used interchangeable in a home-built 1 m linear time-of-flight
mass spectrometer in this work and was similar to that described previously.43 A schematic
diagram of the home built MALDI TOF MS is shown in Figure 2.3.

Figure 2.3 A schematic diagram of the home built MALDI TOF MS; the ion source has a
ball inlet interface for sample introduction. The ball is rotated by a motor placed outside the
ion source. There are two side ports on each side of the ionization chamber; one port is used
to focus the laser into the ball inlet while the other port is used to view the ball in order to
align the sample to the laser. The instrument has a 1 meter linear time-of-flight mass
analyzer and a detector placed at the end of the flight tube. The laser triggers the
oscilloscope to digitize the signal from the detector for downloading into a computer.
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2.2.3

On-line Sample Transport Mechanism

The rotating ball serves as a mechanical transport mechanism that introduces sample
deposited on its surface to the ionization chamber.41,

42

To test the sample transport

mechanism, a Teflon rod mounted on a ring stand was used to hold capillaries in contact
with the ball. Two holes were drilled through the rod for mounting two dual-lumen tubing
sleeves. One sleeve held a sample capillary, and the other held the matrix capillary. Sample
deposition occurred first, followed by matrix deposition on the same spot while the ball
rotated as shown in Figure 2.4.

Figure 2.4 An illustration of the rotating ball inlet sample transport mechanism; sample
deposited on the surface of the ball is rotated past a polymer gasket and interrogated with a
laser aligned with the sample trace. Once the trace passes out of the desorption region, its
cleaned with a solvent saturated felt placed in contact with the ball outside vacuum before
subsequent deposits are made.

The ball was cleaned on-line using a solvent-saturated felt pad placed in contact with
the ball surface by wiping off the matrix and sample left after the desorption process to
regenerate the surface for subsequent sample deposits. The cleaning solvent was delivered to
the felt pad using a syringe pump (model 2374, Harvard). The sample deposition is similar
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to the bottom layer method.46 A solution of 50 mM α-cyano-4-hydroxycinamic acid
dissolved in methanol served as the matrix and was delivered onto the rotating ball by a
syringe pump (Model 55-2222, Harvard) at a flow rate of 0.5 µL/min. The matrix solvent
evaporated upon deposition onto the ball leaving a uniform 300 µm-width trace of matrix
and analyte. The sample trace had to pass the polymer gasket seal in order to enter the
ionization chamber.
2.2.4

Materials

The MALDI matrices, α-cyano-4-hydroxycinamic acid (α-CHCA, C-2020),
sinapinic acid (SA, 85429), 2, 5-di-hydroxy benzoic acid (DHB; G-5254), caffeic acid
(60018, Sigma), nicotinic acid (72311), succinic acid (14078), 2-(4-hydroxyphenylazo)
benzoic acid, (HABA; 54793), and peptides, bradykinin (B-3259), [Met-OH11] substance P
(S-2136), neurotensin (N-6383), [Lsy8] vasopressin (V-6879), peptide separation buffer (P2188) and insulin (I-5500) were obtained from Sigma Aldrich (St. Louis, MO) and used as
received without further purification. Matrix solutions were prepared at 20 mg/ml in a
mixture of acetonitrile and water in a volumetric ratio of 1:1. A 1 mg/ml of insulin solution
was prepared in the same solvent system as the analyte.
2.2.5

MALDI Surface Profilometry

One major challenge was to transport samples past the gasket with minimal losses
while still maintaining the vacuum seal. To evaluate sample transport, measurements were
taken to estimate the sample trace thickness, which may vary from one matrix to another. A
study was carried out to characterize MALDI matrix/sample morphology as a function of
sample deposition method with commonly used matrices. Samples were prepared using the
droplet deposition method such as the dried droplet, seed layer, bottom layer, sandwich and
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upper layer deposition. When using the dried droplet method, the matrix and analyte are
deposited on the target in a single solution. The application of a “seed” layer of matrix prior
to the addition of the analyte has been shown to improve crystallization when the matrix and
analyte solution is subsequently added.47-51 Another variation on the dried droplet method is
the sandwich method, where the analyte is deposited on the seed layer, followed by the
separate addition of matrix.52, 53 In the bottom layer method, the analyte is first deposited on
the target, followed by the matrix. Spray deposition has also been reported using pneumatic
nebulization54-56 and electrospray57,

58

for droplet creation. A schematic of these droplet

deposition methods is shown in Figure 2.5.

Figure 2.5 A schematic representation of the droplet deposition methods; dried droplet
deposits matrix and sample at same time, seed layer deposits matrix first then a
sample/matrix mixture follows, sandwich has sample between two layers of matrix, bottom
and upper layer deposits sample and matrix first respectively.

Surface profilometry is a versatile technique that can be used to measure the
thickness of thin films of solid materials on a micrometer scale. A surface profilometer maps
the surface topography of the material by dragging a sharp micron-sized probe across the
sample surface. It uses a mass cantilever system to keep the tip force constant while
scanning. The dimension of the tip dictates the vertical and horizontal resolution, and is
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typically capable of a lateral resolution of 100 nm and nanometer vertical resolution. The
morphologies of matrix compounds α-cyano-4-hydroxycinamic acid, sinapinic acid, 2, 5-dihydroxy benzoic acid, caffeic acid, succinic acid, 2-(4-hydroxyphenylazo) benzoic acid, and
nicotinic acid were studied. Scanning electron microscopy (SEM) and a Tencor surface
profiler were used to observe and characterize the sample morphologies.
The samples were deposited using dried droplet, seed layer, bottom layer, sandwich
and upper layer methods on a standard MALDI sample target. Although the rotating ball
inlet cannot use the sandwich method, the method was included in this study for comparison
of sample preparation thicknesses only. With the dried droplet method, 2 µl of matrix and 1
µl of sample were premixed and deposited on a MALDI target using a pipette and solvent,
which was left to evaporate. For the seed layer preparation, 1 µl of matrix was deposited on
the target using a pipette and left to dry, then 2 µl of a 1:1 mixture of the analyte and matrix
solutions were deposited on the same spot and left to dry. Bottom layer samples were
prepared by depositing 1 µl of analyte on the target using a pipette and letting it dry before 2
µl of matrix was deposited on the same spot. In the sandwich method, 1 µl of matrix was
deposited on target and left to dry, then 1 µl of analyte was deposited on the same spot,
followed by the addition of 1 µl of matrix. For the upper layer approach, 2 µl of matrix was
deposited on the target; upon drying 1 µl of analyte was deposited and left to dry.
A contact surface profilometer (P-11, Tencor, Santa Clara, CA) was used to measure
the thickness of sample deposits prepared using different sample deposition techniques.
Samples deposited on MALDI target are profiled at atmospheric pressure. The MALDI
target was loaded onto the motorized profiler stage and manipulated with software to place it
in position with the profiler tip. The profiler is equipped with a video camera that allows the
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user to position the tip on a desired location and to visualize the sample while scanning takes
place. A Cambridge Stereoscan 260 scanning electrode microscope was used to acquire
SEM images of the sample deposits. A MALDI-TOF MS instrument (Ominiflex, Bruker,
Billerica, MA) was used to analyze samples deposited using the above mention techniques.
The profiler tip was adjusted by eye such that the tip passed through the central of each
sample spot.
2.2.6

Flow Injection Analysis (FIA)

Sample transport past the gasket was first tested using FIA. In FIA, a sample plug is
introduced into a mobile phase using a fixed volume injector. The pressure driven flow of
the mobile phase transports the plug along a column toward a detector placed on one end. A
rotary valve micro sample injector (Model ABR0592, Valco, Houston, TX) was used to
carry out repeated injections. FIA was accomplished by contacting the rotating ball with a
single transfer capillary connected to the outlet of the rotary valve injector. The sample was
introduced manually using a 2 µL sample loop of the injector. The injector valve was then
switched to inject position, allowing a syringe pump (Model 55-2222, Harvard Apparatus)
attached to the inlet of the injector to pump matrix at a flow rate of 2 µL /min through the
transfer capillary and carry the sample plug from the sample loop of the injector onto the
rotating ball.
2.2.7

Capillary Zone Electrophoresis (CZE)

The rotating ball inlet was then tested with capillary electrophoresis (CE)
separations. Fused-silica capillaries 20 cm long with 50 µm i.d. (Polymicron, Phoenix, AZ)
were used for CE separations. A mixture of three peptides was run on an HP

3D

CE system

with a photodiode array detector (Model GX1600AX, Hewlett Packard, Walbron, Germany)
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to obtain optimal separation conditions. The peptide mixture consisted of 60 µM of
vasopressin, substance P, and neurotensin. The optimized separation conditions were then
used to separate the mixture on the CE system interfaced to the MALDI-MS. The homebuilt CE system consisted of sample and buffer vials mounted on an insulating stand, a CE
power supply (CZE 1000R, Spellman, Hauppauge, NY) and another power supply for the
ball interface (Gamma High Voltage Research, Ormond Beach, FL). The two power
supplies were connected to share the same ground. The ball acted as the CE cathode and was
held at 10-kV positive potential necessary for ion acceleration (see Figure 2.6). The capillary
anode was biased at 18-22 kV relative to ground and 8-12 kV across the 20-cm capillary.
Field strengths between 400 and 600 V/cm were used for all separations, and electrokinetic
injections were performed at 400 V/cm for 10 s. A 50 mM phosphate electrolyte at pH 2.5
was used as the separation buffer.

Figure 2.6 A schematic representation of the rotating ball inlet interface for CE-MS
indicating (A) ball, (B) driveshaft, (C) Teflon gasket, (D) ISO-100 flange, (E) extraction
lens, (F) matrix capillary, (G) buffer capillary, (H) anode and running buffer, (I)
electrophoresis capillary, (J) cleaning solvent capillary, (K) felt pad and holder, and (L)
solvent drain.(Reproduced with permission from Anal. Chem.2004, 76, 5968-5973.
Copyright, 2004 American Chemical Society)
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In CE mode, one of the dual lumen sleeves held the separation and make-up buffer
capillaries, while the other sleeve held the matrix capillary. The CE system was operated
manually by switching the separation capillary from the buffer vial to sample vial during
injections. The separation capillary was rinsed and conditioned between runs for 2 min with
methanol and then buffer. A 50 mM phosphate supporting electrolyte was supplied through
another capillary via a syringe pump (Model 55-2222, Harvard Apparatus) at a flow rate of
0.5 µL/min to the separation capillary tip, which was in contact with the ball to keep the
electrical connection. At pH 2.5, the capillary supports a low EOF and also suppresses
analyte adsorption to the capillary wall.59 The peptides used in this study had pI values
above the buffer pH and, thus, were expected to be positively charged.
2.2.8

Data Acquisition

A 500 MHz digital oscilloscope (Model LT372, LeCroy, Chestnut Ridge, NY) was
used to record mass spectra. Communication with the oscilloscope was accomplished using
a personal computer (Apple, Cupertino, CA) via general purpose interface bus (GPIB). The
oscilloscope was externally triggered by the laser output signal and remotely controlled by
in-house LabView software (National Instruments, Austin, TX) for downloading averaged
mass spectra. The mass spectra were averaged over 10 laser shots with 50 000 data points
and a flight time resolution of 1 ns per data point. The mass spectra were downloaded and
stored over 1s integration times as the experimental data collection progressed in real time.
Since the laser duty cycle was 10 Hz and each mass spectrum was an average of 10 laser
shots integrated over 1s, the file download duty cycle of ~1s per mass spectrum using a
GPIB interface allowed 50 % of the mass spectra acquired to be recorded. Following data
acquisition, stored mass spectra were processed with in-house LabView programs. Two-
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dimensional CE-MS plots were generated using NIH Image and Image J software (National
Institutes of Health, Bethesda, MD).
2.3

Results and Discussion

2.3.1

Surface Profilometry

Surface characterization using a profilometer is a simple and fast technique for
measuring film thickness and requires no special sample preparation prior to scanning.
Samples deposited at ambient pressure on a MALDI target were left to dry upon which the
MALDI target was loaded onto the profiler programmable motorized stage and placed in a
desired location under the profiler tip with the help of software control and a video camera.
Surface profiles generated from different matrices deposited using the dried droplet
methods are shown in Figure 2.7. The profiles demonstrated that the sample thickness varied
greatly with the matrix by more than an order of magnitude for matrices prepared from
solutions of the same volume and concentration. The CHCA, HABA and SA deposits are
relatively thin, all being under 100 µm in thickness. Succinic acid and DHB were relatively
thicker at approximately 0.5 mm average thickness. The sample morphology was obviously
heterogeneous as a result of different sizes of the matrix crystals as indicated by varying
thicknesses for each matrix profile.60, 61 The profiles for the dried droplet deposit variations
(seed layer, bottom layer, sandwich and upper layer) were qualitatively similar to the dried
droplet results. The roughness of the sample morphologies varied as a result of different
sizes of the matrix crystal matrix. An estimate of the roughness for each matrix could be
computed from the ratio Ra / λa, where Ra is the average deviation of peak height in microns
of random points in a typical surface profiler trace and λa is the average distance between
peaks of the surface features in a typical surface profiler trace.
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a. α-CHCA

b. DHB

c. Succinic

d. HABA

e. Sinapinic

Figure 2.7 Surface profiles of dried droplet sample deposits obtained from α-CHCA, DHB,
Succinic, HABA and SA MALDI matrices. The scan length and height units are in µm and
were obtained by scanning a surface profiler tip horizontally along and over the matrix
deposits with a 2 mg-force applied on the stylus and steps (scan speed) of 20 µm/sec.
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A bar graph representation of the measured sample film thicknesses for the dried
droplet deposition methods is shown in Figure 2.8. The data resulted from ten replicate
measurements and the error bars in Figure 2.8 correspond to one standard deviation. The
average thickness was obtained from surface profiles by averaging the deviations in height
at random points. The multi-layer deposition methods (sandwich, bottom, upper and seed
layer) were consistently less thick compared to the single dried droplet deposit. This was
likely due to the second solution deposit dissolving the crystals that were formed by the first
solution deposit. DHB and SA were consistently the thickest samples within a particular

Thickness in microns

deposit method while HABA and CHCA were the thinnest.
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Figure 2.8 Droplet thickness variations in samples deposited using the dried droplet,
sandwich, bottom, upper and seed layer methods. Dried droplet was consistently thick
compared to the other techniques that require multiple layers deposition approach as shown
in the bar graph
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The corresponding data for the bar graph shown in Figure 8 is presented in the Table 2.1
below.
Table 2.1 Surface profile average thickness by all matrix and droplet deposit methods
Deposition
method
Dried droplet

αCHCA

Sinapinic

DHB

Caffeic

Succinic

HABA

Nicotinic

40±16µm

135±22µm

600±20µm

80±18µm

500±136µm

36±7µm

85±20µm

Seed layer

18 ±2µm

85 ±18µm

350±35µm

70±13µm

180 ±35µm

10±2µm

40±17µm

Bottom layer

22 ±5µm

90 ±27µm

225±33µm

50±10µm

120 ±23µm

5 ±1µm

60 ±7µm

Sandwich

24 ±6µm

80 ±10µm

500±45µm

50±14µm

250±35 µm

5±1 µm

65±15µm

Upper layer

30 ±5µm

70 ±7µm

250 ±2µm

60±12µm

135±33 µm

8±1 µm

27±2 µm

From these measurements, α-CHCA a standard solid matrix commonly used for low
molecular weight peptides and proteins gave thin matrix/sample deposits compared to
DHB. Although HABA deposits were comparable in thickness to α-CHCA, HABA was not
selected because it was not a suitable matrix for the samples used. The bottom layer
approach is more suitable for the rotating ball inlet when the matrix and sample have to be
introduced separately. Again for the bottom layer approach, α-CHCA is a preferred matrix
than HABA for the analysis of low molecular weight peptides and proteins. Measurements
were then taken to estimate the surface roughness of the ball and the thickness of α-CHCA
matrix/sample deposits prepared by drag contact droplet deposition from a capillary as the
ball was rotating. The ball assembly was removed from the flange after the sample was
deposited on-line. Different portions of the matrix/sample trace on the ball surface were
measured by scanning a length of 2 mm at 20 µm/s with a 2 mg-force applied on the stylus.
Ten replicate measurements were made to ascertain the ball roughness and the
matrix/sample deposit thickness before and after the trace passes past the gasket seal.
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Surface profile measurements on the rotating ball are shown in Figure 2.9. The
profile of the ball surface after coating with a solution of 50 mM α-cyano-4-hydroxycinamic
acid dissolved in methanol at a flow rate of 2 µL/min is shown in Figure 2.9a. The scan was
perpendicular to the direction of the track; the thickness of the sample and matrix deposit
before it passes under the gasket was 15 µm. After the track passes under the gasket, the
thickness is reduced to 10 µm, as indicated in Figure 2.9b. At the edges of the track, the
deposit is slightly thicker at 12 µm. These results indicate that approximately one-third of
the sample deposit is scraped off the ball surface as it passes into the vacuum system. The
uncoated ball surface is shown in Figure 2.9c. The unpolished ball surface has indentations
~2 nm deep and 500 nm in diameter with an aspect ratio of 0.004, obtained by dividing the
depth with diameter.

Figure 2.9 Surface profiles obtained on the surface of the rotating ball: (a) ball surface
coated with sample, (b) ball surface after the sample deposit has passed under the polymer
gasket, and (c) the uncoated ball surface. (Reproduced with permission from Anal.
Chem.2004, 76, 5968-5973. Copyright, 2004 American Chemical Society)
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2.3.2

Flow Injection Analysis (FIA)

The performance of the interface was compared between a static and on-line mode of
operation of the stainless steel ball using a flow injection analysis (FIA) set-up. Figure 1.10
shows mass spectra of bovine insulin in static and continuous flow mode with FIA. The
mass spectra are an average of 20-shot spectra obtained with the acceleration voltage set at
10 kV. In both cases, the samples were deposited on the rotating ball at atmospheric
pressure. A 2µl sample of 20 µM solution of insulin was injected with FIA and deposited on
the ball at a flow rate of 2 µL/min using a matrix solution that was continuously infused
with a syringe pump. In static mode (Figure 10a), the ball rotation was stopped, and after
breaking vacuum, the ball was manually rotated to align the sample track with the laser and
restore vacuum before acquiring the mass spectrum. For on-line operation, the ball was
rotated continuously at 0.3 rpm, and the sample track passed under the Teflon gasket before
entering the mass spectrometer. At this rate of ball rotation, the solvent evaporated from the
ball surface before the sample reached the gasket. Although acquired from rotational and
static mode of ball operation, the resulting mass spectra were nearly identical in signal
intensity and mass resolution. The mass spectrum in Figure 2.10b has a greater contribution
from low-mass signal, possibly due to salts or other contaminants picked up from the gasket
surface. The other mass spectrum in Figure 2.10a which was deposited on the ball and
placed into the vacuum without passing under the gasket seal has less contribution from low
mass signals. In both cases, the [M + 2H] + and the [2M + H] + adduct peaks were observed
but the [M + H] + was still the most intense peak in the mass spectra. The mass spectral data
indicated that, although much of the sample deposited was removed from the ball surface,
with on-line operations, there was still sufficient material left to generate mass spectra.
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Figure 2.10 Mass spectra acquired from a 2µl sample of 20 µM insulin sample mixed with
20 mM α-cyano-4-hydroxycinamic acid matrix in (a) static ball mode by pipetting onto the
stationary ball, and placing the sample portion on the ball into the vacuum without passing it
under the gasket and (b) continuous flow mode on the rotating ball using flow injection
analysis. (Reproduced with permission from Anal. Chem.2004, 76, 5968-5973. Copyright,
2004 American Chemical Society)

2.3.3

Capillary Zone Electrophoresis (CZE)

To achieve successful operation for CE with the rotating ball as the cathode and
transfer interface to MALDI-MS, two parameters were critical in preserving the separation
efficiency: the linear speed of the ball and the flow rate of the makeup buffer. First, the
makeup buffer flow rate was critical in keeping the capillary tip wet for stable currents;
however, caution was taken to minimize zonal dispersion. The makeup buffer was delivered
by a syringe pump at a flow rate of 8 nL/s, which is typical of bulk solution flow in CE
experiments.12 Second, the linear speed of the ball was selected to minimize the sample
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zonal dispersion arising from the finite detection volume. It was initially anticipated that
matching the linear speed of the ball with the velocity of the species migrating through the
separation capillary would preserve the separation efficiency; however, this was found not to
be the case.
A plot of separation efficiency (plate number) as a function of ball rotation rate is
shown in Figure 2.11. This plot was obtained from single ion electropherograms of the
peptide bradykinin obtained at different linear velocities of the ball. The plate numbers were
obtained from the relationship N= L2/ σ2total, where L is the length of the separation
capillary. For this calculation, it was assumed that the major contribution to the total peak
dispersion (σ2total), for UV detection was longitudinal diffusion and therefore σ2total ~
σ2Diffusion.

Figure 2.11 A plot of theoretical plate numbers (separation efficiency) as a function linear
speed of the rotating ball. The plate numbers were calculated an individual peak at varying
linear speeds of the ball inlet. At low linear velocity better separation efficiency was
observed compared to high linear velocity. (Reproduced with permission from Anal.
Chem.2004, 76, 5968-5973. Copyright, 2004 American Chemical Society)
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Because the separations were first optimized using UV detection, the value for
σ2Diffusion was obtained from the UV trace in Figure 2.14. Operating the ball at high linear
velocity did not allow enough time for the sample, make-up buffer and matrix deposits to
dry by solvent evaporation before passing the gasket vacuum seal. As results,
smearing/lateral spreading at the ball-gasket contact point for wet samples significantly
affected the resolution and hence the separation efficiency at the detection point. This is
because at higher rotation rates, contributions to the total peak dispersion resulted not only
from longitudinal diffusion but also from the finite detection volume as well: σ2total ~
σ2Diffusion + σ2detector, where σ is the peak dispersion.62, 63 Further, the number of data points
acquired for characterizing peak profiles as they passed through the detection point at high
linear velocity of the ball was limited by the laser duty cycle. However at very low linear
speed of the ball, it was predicted that the resolution and hence separation efficiency would
be limited since separated components would elute to the same position resulting. Very low
linear speeds were not investigated because the analysis would take a long time and
significantly reduce the intended sample throughput associated with this on-line approach. A
linear speed of 0.04 rpm was chosen as the optimal speed of the ball for CE separations in
order to preserve the CE separation efficiency (104 plates per meter) and to operate at
acceptable sample throughput. At the optimized speed, the separation efficiency at the
detection point was improved possibly due minimal lateral spreading or smearing at the
gasket-ball contact point for dry samples that fixed the separated components on the ball
past the gasket seal into the ionization chamber.
The relatively low flow rates observed in the CE mode, combined with the optimized
linear speed of the ball resulted to a narrow (200 µm wide) sample track. Individual sample
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solutions containing 20 µM of the peptides bradykinin, substance P, and neurotensin were
electrokinetically injected into the capillary to gauge their elution behavior in the capillary.
The injected sample volume is estimated to be 5 nL, corresponding to a 100-fmol quantity
for each of the three peptides. Mass spectra of the three peptides acquired after migrating on
capillary and upon deposition on the ball are shown in Figure 2.12. There is a significant
contribution to the mass spectra from impurity peaks in the low m/z region, but the mass
spectra are free of detectable interference peaks above m/z 700. The mass resolution of these
peptide peaks was calculated to be ~ 250 by fitting a Gaussian distribution at half height on
the peak profile using in-house algorithms. This mass resolution is low and may be
improved by using a reflectron in the flight tube or delayed extraction in the ion source

Figure 2.12 Mass spectra obtained on-line on the surface of the rotating ball after individual
electrokinetic injections of 100-fmol samples of (a) bradykinin, (b) substance P, and (c)
neurotensin. (Reproduced with permission from Anal. Chem.2004, 76, 5968-5973.
Copyright, 2004 American Chemical Society)
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A separation of the three peptides, vasopressin, substance P, and neurotensin, was
carried out, and a two-dimensional contour plot was generated on a grayscale map, as shown
in Figure 2.13. The migration times were determined by first injecting the individual
peptides and selective ion monitoring at their corresponding m/z. The x-axis corresponds to
electrophoresis time, the y-axis corresponds to m/z, and the third dimension of signal
intensity is represented by the grayscale at a particular m/z and migration time. Substance P
was detected at 14.80 min, vasopressin at 15.75 min, and neurotensin at 16.80 min. Low
m/z interfering peaks from matrix and running buffer are seen as the dark stripes across the
bottom of Figure 2.13. Data acquisition was initiated at 5 min. The drift in m/z of the
interference peaks was a symptom of drift in the high voltage power supply connected to the
interface flange.

Figure 2.13 A two-dimensional representation of a CE-MALDI separation of the peptides
substance P, vasopressin, and neurotensin. The grayscale intensity represents the ion signal
at a particular m/z and elution time while the x-axis corresponds to electrophoresis time and
the y-axis corresponds to m/z. (Reproduced with permission from Anal. Chem.2004, 76,
5968-5973. Copyright, 2004 American Chemical Society)
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A comparison between a UV detector eletropherogram and the mass spectral
electropherogram is shown in Figure 2.14. This was done to assess peak profiles as eluted
from the separation capillary onto the interface for detection. A photodiode array
electropherogram (obtained from a different run under nominally identical conditions) is
shown. The single ion electropherograms obtained by integrating the ion intensities along
the x-axis for the data in Figure 2.13 are overlaid above the corresponding photodiode array
electropherogram peaks. The integration limits were set to ± 0.5 µs about the peak of
interest. The calculated plate numbers for UV trace and the single ion electropherogram
were ~104, evidence that the separation efficiency was preserved with optimized linear
speed of the rotating ball interface.

Figure 2.14 Selected ion electropherograms of substance P, vasopressin, and neurotensin
obtained from Figure 2.13, plotted above a photodiode array detector electropherogram
obtained from a different run under nominally identical conditions monitored at 214
nm.(Reproduced with permission from Anal. Chem.2004, 76, 5968-5973. Copyright, 2004
American Chemical Society)
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Another important parameter for the optimization of the detector performance is the
laser repetition rate, which sets the sampling rate. The repetition rate should be fast enough
to sufficiently characterize peak profiles eluting from the separation capillary. From the peak
widths detected on the separation capillary and with the interface operated at the optimized
linear speed of 0.04 mm/s, an average electrophoretic peak width of 20 s resulted. With a
laser duty cycle of 10 Hz, ~100 data points were collected for each peak with a download
duty cycle of ~1 s. The time-of-flight (TOF) mass analyzer has an intrinsic advantage of fast
acquisition rates, which provides an extremely short time to produce a full mass spectrum.64,
65

This allows a large number of mass spectra data per unit time to be acquired for efficient

characterization of CE separation peak profiles.
2.4

Conclusion

We have demonstrated a new rotating ball interface for online MALDI, in which the
majority of the ball surface is at atmospheric pressure and easily accessible for sample
deposition. Samples can be deposited on the ball surface, where they dry and are delivered
into high vacuum of a MS past a polymer gasket seal. The ball surface is interrogated by
MALDI and then cleaned on-line after it passes out of the ionization chamber for subsequent
sample deposits. A CE separation of three peptides, substance P, vasopressin, and
neurotensin, was demonstrated. Optimization of the makeup buffer flow rate and the ball
rotation rate was critical for maintaining separation efficiency. Continued development of
the rotating ball interface is focused on coupling microfluidic chip separations to MALDI
using this interface. Improvements in mass resolution for the TOF instrument can be
obtained by either implementing delayed ion extraction or adding a reflectron in the mass
analyzer or both.
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CHAPTER 3. DIRECT COUPLING OF POLYMER-BASED MICROCHIP
ELECTROPHORESIS TO ON-LINE MALDI TOF MS USING A
ROTATING BALL INLET
3.1

Introduction

3.1.1

Microfabrication Techniques for Polymer-Based Microfluidics Devices

Microfluidic devices have been fabricated in various materials such as glass, silicon
and polymer.1-4 The choice of substrate material is dependent on physical properties such as
optical clarity and glass transition temperature, chemical properties such as solvent
compatibility and surface chemistry, electrical properties such as dielectric strength, thermal
conductivity and expansion coefficients, availability and ease of machining.5 The material’s
physical and chemical properties play a significant role in microfabrication, sample handling
and processing within a microfluidic device. In departure from originally used material such
as glass and silicon, there has been a recent shift to polymer-based microfluidic devices.6
Polymers exhibit a wide range of surface properties such as wettability, adsorption and zeta
potential,7, 8 depending on chemical functionality. Such physico-chemical properties affects
sample processing, experimental conditions and quality of data in diverse ways.5 Often,
different surface modification chemistries are required on polymer substrates to tailor the
surface to the sample processing needs.
Polymers are easy to machine and the microfabrication process is cost effective for
mass production. Microstructures can be fabricated directly onto polymers using laser
ablation, micromilling or wire imprinting techniques. An alternative approach involves
microfabrication of a molding master with desired microstructures using high precision
micromilling or photolithographic techniques,6,

9-11

then using polymer replication

technologies such as hot embossing or injection molding to transfer microstructures and
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micro-part onto polymer substrates.10,

12

Once stamped out, the devices are assembled by

thermally annealing a cover plate to enclose the micro-structures patterned onto the polymer
substrate.
One example of a photolithographic technique used for the microfabrication of a
molding master is LIGA, a German acronym for lithography, electroplating and molding.2
Initially, a desired microfluidic network is designed using computer-aided design (CAD)
software. The design is transferred to an optical mask which consists of a chromium coated
quartz plate with a positive photoresist layer on top. An X-ray mask is developed from the
optical mask after exposure to UV radiation. The chromium coating on the optical mask
blocks UV radiation while exposing a resist-coated kapton film coated with a gold plating
layer which serves as an X-ray absorber. The developed X-ray mask is then aligned over a
layer of PMMA bonded onto a stainless steel plating base for exposure to X-rays. PMMA in
this case serves as an X-ray photoresist. The exposed PMMA layer disintegrates and can be
removed with an appropriate solvent leaving behind the unexposed PMMA parts, the
resultant voids are filled by electroplating Ni. The Ni electroform molding master is then
mechanically polished with the intact PMMA parts serving a support material for the raised
Ni microstructures. The master can then be used for replication of the microstructures either
using hot embossing or injection molding. LIGA is the preferred method when fabricating
sub-micron sized features of microstructures that require extremely high-aspect ratio in a
microfluidic device. A schematic diagram of procedures involved in the micro-fabrication of
mold inserts using the LIGA (lithography, electroplating, and molding) technique and
replication in polymer substrates using a hot embossing technique is illustrated in Figure 3.1.
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Figure 3.1 A schematic illustrating the steps involved in the microfabrication of mold
inserts using LIGA technique and replication of the microstructures using molding
technique; (a) X-ray or UV exposure of synchrotron radiation to a photoresist with an X-ray
mask, (b) development of exposed area and electroplating the voids, (c) mechanical
separation of the electroform metal structure from the starting base plate then molding
polymer substrate using the mold insert.

A high precision micromilling machine can also be used to fabricate a molding
master by micromilling the desired microstructures onto a brass plate. The milling machine
is capable of achieving positional and repetition accuracy of ±1 µm by use of a laser
measuring system and an optical microscope. Varying sizes of solid carbide milling bits
operating at different feed rates are employed for milling and rapid prototyping of desired
microstructures on brass plates. The sizes of features that can be fabricated using
micromilling technique are limited by the size of the milling bit. The burrs created at the
upper surface of the microstructures after milling are removed by mechanical polishing
before the master is used for replication of microstructures with the hot embossing
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technique. A digital picture of a Kern high precision micromilling machine used for the
microfabrication of mold inserts is shown in Figure 3.2.

Figure 3.2 A Kern high precision micromilling machine and milling bits used in the
microfabrication of mold insert on brass plates.

Replication of polymer micro-parts can be accomplished using hot embossing.1,

9

Hot-embossing is an easy and cost-effective method for reproduction of large numbers of
identical polymer devices with similar microstructures. The molding master is mounted onto
a temperature controlled fixture and the planer polymer substrate sandwiched between the
molding master and an evacuated embossing chamber at controlled temperature and
pressure. The assembly is heated and pressed for a specified time and upon cooling, the
molding master is mechanically separated from the polymer substrate, which already has the
desired featured embossed onto the surface. Hundreds of devices can be made from one
master, allowing for rapid prototyping and cost-effective mass production of polymer
microfluidic devices. The final step of assembling a microfluidic device involves cleaning
the embossed microstructures and thermal bonding of a cover plate at a controlled
temperature to enclose the embossed microstructures and to allow for fluidic transport
within the microfluidic channel network.
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3.1.2

Integration to Biological Mass Spectrometry

Most of the early work in coupling microfluidics devices to biological mass
spectrometry focused on electrospray ionization (ESI).13-24 On-chip CE ESI-MS has some
drawbacks associated with the non-compatibility of ESI with aqueous buffers and the need
to decouple separation voltage from ESI voltage.25 Further, the generation of ESI directly
from the chip usually results in a large droplet constituting a highly mixed volume, limiting
the utility of upstream separation.25 It is also worth noting that the directional control of the
spray can be difficult for a high density array of spray tips, potentially leading to crosstalk.23,
26

In some cases, the sprays can be difficult to start and stop because they are heavily

dependent on the tip geometry and the liquid phase. Microfluidic chip interfaces with ESI
also suffer from problems when sprays are started or stopped and this limits the speed of
moving from one sample to another and hence less desirable for high throughput
applications. However, the obvious preference of ESI interfaces between microchips and
mass spectrometry is due to the fact that ESI is a continuous liquid introduction technique
and therefore naturally easier to implement in microfluidics.
Nonetheless, ESI and MALDI are complementary techniques that provide soft
ionization of biomolecules in liquid and solid samples respectively. A few works have been
reported on on-line

27-30

and off-line

31-36

coupling of micro-column separations to matrix

assisted laser desorption ionization (MALDI). Unlike ESI, MALDI is essentially a solid
sample technique that employs an excess of solid matrix crystals as host for guest sample
molecules.37 Recent studies have also shown that MALDI can work with liquid matrices
when infrared lasers are employed for desorption and ionization.38 MALDI has the strengths
of high tolerance to impurities such as buffer additives, a wide mass range, easily interpreted
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mass spectra and the potential for high throughput sampling availed for by rapid switching,
such as a fast x-y translation stage or a galvanometer-driven mirror. Limitations of off-line
MALDI have resulted in efforts towards the developments of rugged and robust interfaces
for on-line MALDI,39-43 that can delivery sample continuously into vacuum in real time and
thereby exploit the potential for high throughput sampling.
Recently, an on-line continuous pressure driven self-activating flow on-chip
microfluidics device connected to a MALDI-TOF mass spectrometer was reported.30 The
integration was achieved by placing the micro-device on a standard MALDI sample plate,
which had a rectangular hole milled to fit the entire device. The reagents were loaded on the
device off-line before mounting it into the mass spectrometer ion source. Chemical
syntheses as well as biochemical reactions were carried out under vacuum inside the
MALDI-MS ionization chamber and the products analyzed by MALDI-TOF MS. The
device was later modified to include a sub-micron hole for monitoring the kinetics of
chemical reactions in real time using MALDI MS.29
Previous works on integrating microfluidics to MALDI MS have reported either offline electrophoresis,36 or off-line manipulation of samples in the fluidic channel using a
centrifugal force,34 electrowetting-on-dielectric,33,

35

or on-line continuous pressure driven

self-activating flow.29, 30 We report here the integration of microchip electrophoresis to online MALDI MS. The coupling of MALDI MS to microchip electrophoresis employs a
direct contact deposition approach to transfer samples eluting from a microfluidic device
onto a rotating ball inlet.44 Samples deposited at atmospheric pressure are transported into
the high vacuum of the mass spectrometer without breaking the ion source vacuum. The
interface has the advantage of decoupling the ionization process from the separation step.
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This is important in optimizing the separations and ionization process independently without
compromising the sample processing step and overall system performance. The interface
performance was demonstrated by the separation of peptides and a proteolytic digest of a
model protein with subsequent MALDI MS detection of the generated peptide fragments.
3.2

Experimental Section

3.2.1

Reagents and Methods

Bradykinin (B-3259), [Met-OH11] substance p (S-2136), bombesin (B-4272),
cytochrome C (C-2506), peptide separation buffer (P-2188), α-cyano-4-hydroxycinamic
acid (C-2020), ammonium bicarbonate (A-6141), trypsin digestion buffer and trypsin (T6567) were all obtained from Sigma-Aldrich (St. Louis, MO). The separation buffer
(phosphate, pH 2.5) stock solution was diluted to 10 mM in de-ionized water and sonicated
for 15 minutes before use. The peptides bradykin, substance p and bombesin were prepared
to a concentration of 10 µM in the phosphate buffer. A 50 mM solution of α-Cyano-4hydroxycinamic acid (α-CHCA) prepared in methanol and 0.1 % trifluoroacetic acid (TFA)
was used as the MALDI matrix.
Tryptic digestion: A 50 mM ammonium bicarbonate digestion buffer was prepared in
de-ionized water. A 20 µM solution of cytochrome c was prepared in the ammonium
bicarbonate digestion buffer whereas trypsin was prepared in trypsin reaction buffer
obtained from Sigma-Aldrich (T-6567, St. Louis, MO). Cytochrome c (20 µM) and trypsin
(0.1 mg/ml) solutions were then mixed in 50:1 (w: w) ratio and incubated for 18 h at 370C.
The reaction was stopped by the addition of 1% trifluoroacetic acid in the incubation
mixture. The digest was thereafter concentrated using a speed vacuum at 400C and
resuspended in a 10 mM phosphate buffer.
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3.2.2

Microchips

A molding tool was first micromilled on a 0.250” thick brass plate (alloy 353
engravers brass McMaster-Carr, Atlanta, GA). The brass plate was cut into a 12 cm
diameter round plate and a specified pattern of microstructures was milled onto the surface
of the brass plate with a high-precision micromilling machine (KERN MMP 2522, KERN
Micro- und Feinwerktechnik GmbH & Co.KG; Germany). The milling machine is capable
of achieving positional and repetition accuracy of ±1 µm by use of a laser measuring system
(LaserControl NT, Blum-Novotest GmbH, Germany) and an optical microscope (Zoom
6000, Navitar, Inc. Rochester, NY). A 50 µm solid carbide milling bit (McMaster-Carr or
Quality Tools, Hammond, LA) was employed for milling the microstructures. The
micromilling was accomplished at a feed rate of 10-20 mm/min for a 50 µm bit and at
40,000 rpm. The burrs created at the surface of the microstructures after milling were
removed by mechanical polishing. The polishing step was done manually, first using a 3 µm
grain size polishing paper (Fibrmet Discs - PSA, Buehler, Lake Bluff, IL) and then with a
polypropylene cloth (Engis, Wheeling, IL) using a 1 µm diamond suspension (Metadi
Diamond Suspension, Buehler). Both the polishing paper and the cloth were attached to 12”
x 12” x 0.25” glass plates obtained from McMaster-Carr. A SEM image of a section of the
mold insert is shown in the right panel of Figure 3.3. The milled pattern had a 8 cm linear
separation channel that was 50 µm wide and 100 µm deep with an offset T-injector with a
fixed volume(Vinj= 10 nL).
The

molding die was then used for replicating polymer micro-parts via hot

embossing as the polymer replication technique on 5 mm thick, 12 cm diameter poly-methyl
methacrylate (PMMA) disks.9,

10, 45

PMMA sheets were obtained from (MSC Industrial
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Supply Company, Melville, NY). The sheets were mechanically cut to 12 cm disks and
baked on the oven at 80 0C for 8 h to remove the residual moisture before embossing.
Embossing was accomplished by first mounting the molding die in a PHI Precision Press hot
embossing machine (Model TS-21-H-C (4A)-5, City of Industry, CA) together with planar
PMMA disks of 5 mm thickness and 12 cm in diameter. Both the die and the PMMA disk
were heated separately in a vacuum chamber to a temperature of 155 oC, just above the glass
transition temperature of PMMA (Tg = 107 oC). The molding die was then brought into
contact with the PMMA substrate and embossed at a pressure of 950 P.S.I for 150 s. The
PMMA-molding die was rapidly cooled to just below the glass transition temperature before
mechanically separating the die from the embossed substrate.

Figure 3.3 A schematic diagram showing the top view of chip to ball direct contact
deposition: (A) sample reservoir, (B) waste reservoir, (C) buffer reservoir, (D) fluidic
channel exit tip, (E) ball. The panels on the right show two SEM images of (1) mold insert
(2) embossed microchip tip. (Reproduced with permission from Electrophoresis, 2005, 26,
4703-4710, Copyright, 2005 Wiley-VCH)

After embossing, the PMMA device was machine cut as shown in Figure 3.3. The
upper circular portion was 8 cm in diameter and the entire device was 10.5 cm long. The
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fluidic channel exit was mechanically cut to a tapered V-shaped tip (see Figure 3.3). The
final device was sonicated and cleaned with water and IPA and air-dried. The channels were
enclosed by thermally annealing a 125 µm PMMA cover slip at 107 oC for 20 min on the
embossed side of the substrate.
3.2.3

Microchip Electrophoresis.

An in-house built high voltage controller, which consisted of four independent power
supplies sharing a common ground, was used to drive the electrophoretic process. Timing
relays were incorporated into the high voltage power supply controller to allow four
different outputs to sequentially carry out the electrokinetic injection, separation and activate
pull back voltages required for minimizing sample leakage from the sample reservoir into
the separation channel. A schematic of microchip electrophoresis configuration is shown in
Figure 3.4.

Figure 3.4 An illustration of microchip electrophoresis set-up; sample injection is carried
out using a fixed volume injection cross when a voltage is applied across the double T
junction of the two side short channels labeled sample and waste where the rotating ball is
placed. The sample plug at the junction is separated along the channel toward the port
labeled waste. The potential at the reservoirs is controlled using a programmable power
supply that employs high voltage relays for switching the potential.

110

The electrical connection to reservoirs A, B and C was via Pt electrodes inserted into
the appropriate wells while that for the fluidic channel exit (tip D, see Figure 3.3) was
through an ISO-100 flange. Microchips were integrated to on-line MALDI MS by adapting
the rotating ball inlet to function as an electrophoresis electrode in addition to sample
transfer and MALDI target function.46, 47 The voltage applied on the rotating ball served as a
reference to operate microchip electrophoresis in a reversed or normal mode and also a
reference for MALDI MS operation in either positive or negative mode. Caution! MALDI
MS and electrophoresis systems use high voltage and must be operated carefully.
The chip was mounted on an electrically insulated holder and attached to a XYZ
micro-translational stage for precise alignment of the channel exit with the matrix trace
deposited on the surface of the rotating ball. Two external current meters were used for
monitoring the current between the sample (A) and waste (B) reservoirs during injection and
also between the buffer reservoir (C) and the ball (E) during separation. The chip was
initially filled with buffer through reservoir C using a syringe until the buffer at the exit of
the fluidic channel was in contact with the ball, which was rotated at 0.2 rpm. The buffer in
reservoir A was removed with a Hamilton syringe and replaced with the sample. The sample
was then immediately injected at a field strength of 150 V/cm for 15 s between reservoirs A
and B while reservoir C and tip D were floating. The high voltage controller was thereafter
switched to the appropriate voltage between reservoirs C and D providing a field strength of
200 V/cm, while floating reservoirs A and B. The pull-back voltages at reservoirs A and B
were activated 10 s after injection to allow the plug enough time to migrate past the second
arm of the offset T-injector. The electrolyte used to prepare the sample and carry out the
electrophoresis was 10 mM phosphate buffer at pH 2.5. These experimental conditions were
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used in all cases unless otherwise stated. The voltage at point D was always set to a lower
positive potential relative to the other reservoirs producing a normal mode electrophoresis
configuration.
3.3

Results and Discussion

In departure from traditional materials such as silicon or glass, we employed
polymers as the substrates of choice for fabricating the separation platform.1, 6 Polymers are
attractive because of the ease of machining and a wide choice in fabrication technologies
that can be employed to manufacture the prerequisite microstructures including replication
using hot embossing.12 The replication technique used is capable of mass production of
devices at high rates and minimum costs making these devices attractive for clinical
diagnostic applications where one-time use is necessary to eliminate false positives and
negatives arising from sample contaminations.1, 6, 9
In this case study, PMMA was a suitable substrate for fabricating the device because
it supports a lower electro-osmotic flow (2.07 x 10-4 cm2/Vs) independent of the pH,43
compared to glass whose electro-osmotic flow varies with pH.48 PMMA is also a low cost
and easy to machine substrate that can readily be molded using hot embossing. The
replication quality of the embossed device was assessed by comparing the aspect ratio of the
microstructures on the master to those embossed on the substrate using microscopy. Thermal
annealing of the device at the glass transition of the polymer allowed assembly of the device
without significantly compromising the integrity of the embossed microstructures. Visual
inspection of the device under a microscope after pealing off a thermally annealed cover slip
did not reveal any collapsed microstructures. An assembled chip was tested for leaks by
manually flowing de-ionized water through the enclosed fluidic channel using a hand-held
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syringe. The planar substrate geometries used to manufacture microfluidic devices have
large area that allow for integrated sample processing and a modular systems approach to
integrate platforms. However, it is worth noting here that the microfluidic planar footprint is
technically different from tubular platforms used in capillary electrophoresis and require
specialized approach when coupling to MALDI MS. This is true when capillary
interconnects for sample transfer from the device to MS is not desired. Indeed, the direct
contact approach eliminates the need for such and thereby circumvents the dead volume and
extra-column broadening associated with capillary sample transfer interconnects.49
In coupling microchip electrophoresis to on-line MALDI MS using the rotating ball
interface geometry, some of the challenges addressed included providing an efficient sample
transfer from the exit of the fluidic channel onto the ball surface, maintaining a stable
electrical connection between the chip and the ball, online matrix addition, sample transfer
into vacuum, laser alignment on the sample trace and the regeneration of a clean ball surface
for subsequent sample deposits. The alignment of the microchip tip to the matrix trace at
atmospheric pressure was accomplished using a xyz micro-translational stage. The laser spot
was aligned with respect to the matrix trace using an adjustable mirror mount and a video
camera. This alignment was critical to achieve optimal signal for the MALDI process; the
sample was deposited beneath the matrix trace in order to be aligned with the laser for
desorption. The microchip’s v-shaped 50 µm tip minimized the surface area of the chip in
contact with the ball. This allowed the sample zones to be transferred from the fluidic
channel by direct contact deposition onto the rotating ball surface with minimal lateral
spreading. The direct contact deposition configuration maintained stable electrical
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connection (and stable current) between the ball and the chip without the need for a make-up
buffer.
Initially, 10 fmol of each test peptides were electrokinetically injected into the
separation channel to determine the migration times. The conditions used were as described
in the experimental section. The corrected migration times were established to be 1.15 min
for bradykinin (m/z 1061), 1.42 min for substance p (m/z 1349) and 1.78 min for bombesin
(m/z 1619). The RSD obtained from three measurements for the migration times was less
that 2 %. Online mass spectra acquired for bradykinin, substance p and bombesin are shown
in Figure 3.5. The mass spectra are plotted from bottom up with bradykinin at the bottom.
The peaks below m/z 500 arise from salts, matrix, matrix fragments and matrix adducts. The
low background in the low mass region of spectrum A, where most matrix and buffer salts
adducts peaks show up could be due to competitive ionization or laser energy effect. No
contamination arising from the dissolution of PMMA by the phosphate buffer was observed.
The mass resolution averaged about 150; however, this value might be improved by adding
delayed extraction in the ion source and/or a reflectron in the flight tube.
A mixture of the three peptides containing 10 fmol of each test peptide was separated
in the 8 cm channel. Experimental conditions used here were as earlier described in the
experimental section. A separation contour plot of three peptides, bradykinin, substance p
and bombesin, generated using the 2D graphing software is shown in Figure 3.6. Also a
single ion electropherogram generated by integration the ion intensities in the 2D contour
plot is shown in Figure 3.6. The gray scale represents normalized signal intensity; the x-axis
represents m/z while the y-axis represents separation and read-out time. In the low m/z
region, several peaks from the salts in the separation buffer and matrix adducts are observed.
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Figure 3.5 Averaged mass spectra from 5 laser shots acquired on-line from electrokinetic
injections 10 femtomoles each of (a) bombesin, (b) substance p and (c) bradykinin.
(Reproduced with permission from Electrophoresis, 2005, 26, 4703-4710, Copyright, 2005
Wiley-VCH)

Figure 3.6 The upper panel represents a two dimensional separation contour plot of a
separation of (a) bradykinin, (b) substance p and (c) bombesin on a PMMA chip. The x and
y-axis represents m/z and separation times respectively while the gray shade shows
normalized ion intensities. The panel below is a representative electropherogram generated
by integrating ion intensities from the 2D separation contour plot. (Reproduced with
permission from Electrophoresis, 2005, 26, 4703-4710, Copyright, 2005 Wiley-VCH)
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Electropherograms were constructed by integrating the signal intensities for the
peaks of interest in the contour plot within a specified m/z window using Image J software.
A typical electropherogram is shown in Figure 3.6 beneath the 2D contour plot and
represents a separation of the three peptides with the corrected migration time scale on the xaxis and normalized intensity on the y-axis. Assuming Gaussian peak profiles, the separation
efficiencies generated in the 8 cm channel were calculated to be approximately 103 plates,
which translated to 104 plates per meter. A comparison of these results was made to those
previously observed using capillary electrophoresis to evaluate the microfluidic advantages.
First, the chip was designed to achieve a higher sample loading leading to improved
sensitivity. Compared to the capillary, samples with a 10 fold lower concentration were
routinely injected in the device and detected. Average linear migration velocity in the chip
was about three times faster than that in the capillary. Apparent mobility is a function of
both the analyte electrophoretic mobility and EOF. The high migration velocity in the chip is
due to the higher EOF of native PMMA (2.07 x 10-4 cm2/Vs), compared to that observed for
fused silica (< 0.5 x 10-4 cm2/Vs) at low pH.48, 50
The linear speed of the ball when coupled to the chip was operated five times faster
(0.2 rpm) than that in capillary electrophoresis. It was possible to operated the ball at higher
linear speed with the chip because, for one, no make-up buffer was required when
interfacing microchip electrophoresis as was the case in capillary electrophoresis.47 This was
because of the presence of a stronger EOF in PMMA than that of glass at low pH. Therefore
sample and matrix deposits dried fast before passing the gasket vacuum seal due to less
aqueous solutions on the ball surface. Secondly, the hydrophobic nature of PMMA
minimized the possibility of droplet formation at the chip’s tapered tip to ball contact point
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that could have caused some sample lateral spreading. Further, separations in the microchip
developed in a shorter time compared to capillary electrophoresis and allowed the ball to be
rotated faster. CE separations took considerably longer time leading to evaporation of the
buffer at the capillary tip, and thereby necessitated the need for a make-up buffer since the
EOF was suppressed at low pH. The above operating parameters resulted in fast analysis
time using the microchip compared to the capillary format and generated comparable
separation efficiencies despite the shorter separation channel
We next analyzed a tryptic digest of cytochrome c by microchip CE interfaced to
MALDI MS using the rotating ball inlet. A tryptic digest of cytochrome c that was
performed off-chip using in-solution digestion protocol was first analyzed off-line in static
mode by manually spotting 1 µL of a premixed tryptic digest and matrix on the ball and then
the spot was rotated into vacuum. Typical mass spectra acquired off-line without a
separation step from the digest are shown in Figure 3.7. The first panel shows the mass
spectrum acquired from a cytochrome c digest while the second panel shows the mass
spectrum obtained from a cytochrome c digest that had been spiked with bradykinin. As can
be seen in the first panel, only a few fragments were detected in the unspiked digest without
a separation step. Moreover, in the second panel where the digest had been spiked with a
high concentration of bradykinin, the fragments from the digest were suppressed and only an
intense bradykinin signal was seen. From these results, the presence of an intense signal
from an abundant fragment often appeared to suppress ionization of the other fragments
present in a digest mixture that were in lower abundance. The cytochrome c digest was next
injected and separated in the micro-device to further test the performance of the coupling.
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Figure 3.7 The mass spectra acquired off line in static mode are shown below the contour
plot and represents (a) cytochrome c digest and (b) cytochrome c digest spiked with
bradykinin. (Reproduced with permission from Electrophoresis, 2005, 26, 4703-4710,
Copyright, 2005 Wiley-VCH)

Figure 3.8 A two dimensional contour plot showing the separation of cytochrome C digest.
The x-axis represents m/z, y-axis represents electrophoresis time, and gray shade represents
ion intensities. Bradykinin (m/z 1061) was continuously infused for mass calibration.
(Reproduced with permission from Electrophoresis, 2005, 26, 4703-4710, Copyright, 2005
Wiley-VCH)
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Based on the off-set T-injector volume, the injected amount was estimated to be less
than 20 fmol. The separation conditions used were the same as described in the materials
and methods section. A separation contour plot of the protein digest is shown in Figure 3.8.
The numbered spots in the contour plot indicate peptide fragments detected from the digest.
The intense peak at m/z 1061 in the contour plot as shown in Figure 3.8 corresponds to intact
bradykinin, which was added in the buffer reservoir C such that it was continuously infused
during the separation of the digest and used for calibration. There are about ten intense
fragments appearing above m/z 700 in the contour plot from the digest that are detected
online, even with continuous infusion of a higher concentration of bradykinin.
There are two intense peaks arising from the auto-proteolysis of trypsin at m/z 1154
and m/z 2211. These peaks where not labeled and therefore not included in the tentative
identifications listed in Table 3.1. As shown here, a separation step was required to improve
the sensitivity of low abundant species when analyzing the digest with MALDI TOF MS.
The detected peptide fragments were given tentative assignments by matching their peptide
masses to those in the MS-digest database expected for a horse heart cytochrome c tryptic
digest. The digest was also analyzed with a MALDI-TOF MS instrument (Ominiflex,
Bruker Daltonics Inc., Billerica, MA) to identify the intense fragment peaks. Tentative
peptide assignments given (using the one letter symbol) to the labeled fragments in the
contour plot are listed in Table 3.1. The sequence coverage for the digested cytochrome c
was estimated to be 62 % based on the sequence information obtained from the tentative
identification assigned to the fragments. Potential sample loss during off-chip digestion and
peptide recovery, non-specific binding of peptide fragments on PMMA or undetected
fragments due to ion suppression effects could account for some of 38 % loss of sequence
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coverage information. We have investigated other polymer substrates with desired
characteristic to complement PMMA surface.5 Indeed the PMMA surface has a water
contact angle of 730, indicating a more hydrophobic surface compared to commonly used
glass devices (350). Unlike optical detection schemes, when a mass spectrometer is the
detector of choice, optical clarity of the polymer substrate is not a requirement thereby
availing many plastics for potential use as the fluidic system. We are also incorporating
digestion chambers onto the device to improve the digestion and protein identification
efficiencies and also reduce any potential sample losses associated with processing and
transfer steps.
Table 3.1 A listing of tentative assignments of peptide fragments by PMF.
Start End Missed
Sequence
Pep. Predicted observe Da.
ID

Mass

d Mass

Error ±

Cleavages

1

780.02

780.06

+0.04

80

86

0

(K)MIFAGIK(K)

2

806.98

803.50

-3.48

73

79

1

(K)KYIPGTK(M)

3

908.20

909.40

+1.40

80

87

1

(K)MIFAGIKK(K)

4

1036.37

1038.50

+2.13

80

88

2

(K)MIFAGIKKK(T)

5

1169.33

1170.85

+1.52

28

38

0

(K)TGPNLHGLFGR
(K)

6

1297.51

1297.60

+0.90

28

39

1

(K)TGPNLHGLFGR
R(T)

7

1471.57

1472.10

+0.53

40

53

0

(K)TGQAPGFTYTD
ANK(N)

8

1496.68

1496.48

-0.20

61

72

0

(K)EETLMEYLENP
K(K)

9

1640.86

1640.10

-0.76

61

73

1

(K)EETLMEYLENP
KK(Y)

10

2082.39

2086.20

+3.81

56

72

1

(K)GITWKEETLME
YLENPK(K)
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3.4

Concluding Remarks

We have described the coupling of a PMMA microfluidic device to online MALDI
TOF MS using a rotating ball interface. The approach was simple in design and did not
employ a sample transfer capillary connection from the fluidic channel to the mass
spectrometer. This eliminated any broadening of the electrophoresis peaks associated with
extra column effects,46 material mismatch and automates MALDI sample preparation. The
coupling was robust and showed high separation efficiencies and improved sensitivity with
routine analysis of samples in the lower femtomole range. Although MALDI MS is credited
for a high tolerance of impurities, the sensitivity of low abundant species is often
compromised in complex samples due to ion suppression effects. Coupling microchip
electrophoresis to MALDI MS is one way of simplifying complex mixtures before analysis,
and thereby improving the sensitivity of constituents present in low abundance. To improve
the mass resolution, mass accuracy and mass range, we are modifying the home built
instrument to incorporate a delayed extraction in the ion source and a reflectron in the flight
tube, respectively.
3.5
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CHAPTER 4. A SOLID-PHASE PROTEOLYTIC MICRO-REACTOR FOR
EFFICIENT DIGESTION AND IMPROVED PROTEIN IDENTIFICATION
WITH MALDI MS
4.1

Introduction

Sample processing for proteomic applications requires high throughput and
automated technologies to accelerate target identification and biomarker discovery.1 Most
sample preparation protocols, for example protein digestion, are time-consuming and labor
intensive taking on average 6-24 h and are prone to sample losses and manual handling that
may introduce contaminants, such as human keratins.2-4 Digestion of proteins to peptides is
an important step when mass spectrometry is used for the identification of proteins. Peptides
have lower molecular weights compared to proteins and their masses can be measured with
higher accuracy using mass spectrometers. Protein digestion can be accomplished using
chemical or proteolytic cleavage methods as discussed in Chapter 1. The choice of cleavage
method is dependent on the type and objective of the study; for example, chemical cleavage
using hydrazine cleaves all of the peptide bonds yielding amino-acyl hydrazides of all the
amino acids present in a protein and is mostly used to determine the amino acid composition
of proteins. On the other hand, proteolytic cleavage is specific to particular amino acid
residues depending on the mechanism of action of the protease employed and is used to
study structural modifications of proteins or identification of proteins using their peptide
maps.
For proteomic applications, there are two popular approaches used for elucidation
protein composition namely; “shotgun” or “bottom-up” were proteolysis is routinely
performed before protein identification using mass spectrometry. In the bottom-up approach,
a mixture of proteins is first separated using two-dimensional gel electrophoresis and the
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visualized proteins band are excised from the gel for digestion using in-gel-based protocols.2
In the shotgun approach, a mixture of proteins is first digested using solution
(homogeneous) protocols followed by multidimensional separation before analysis with
tandem mass spectrometry to identify the original proteins.5 In both approaches, protein
identification with mass spectrometry is mostly performed using peptide mass fingerprinting
(PMF), where peptide masses generated from the proteins are subjected to a protein database
search for identification.6
The protein identification efficiency using PMF is often limited by the extent of
proteolytic digestion.3,

7

For example in the shotgun approach, protein identifications are

based on the assumption that the digestion of all proteins in the mixture is driven to
completion. However, it is known that digestion of a complex protein mixture is limited by
the physical properties of the proteins, poor solvation, denaturation, inadequate local
enzyme concentrations, autodigestion, insufficient reaction times, and long incubation times,
degradation of proteins below the detectable molecular weight range.4,

7

During long

incubation times, some peptide fragments remain intact but they may also undergo chemical
modifications such as deamidation, oxidation and increased trypsin autolysis products,
thereby complicating peptide mass assignments during PMF.7-10 Further, some of the
generated fragments within the incubation mixture compete for and / or inhibit protease
activity.11-13 Modifications to standard digestion protocols for example reaction time, local
enzyme concentration, inclusion of reduction, alkylation and on-column digestion rather
than incubation tubes have been demonstrated to generate large improvements in the
identification of proteins present in a sample, hence pointing to the fact that digestion is a
major limiting factor in protein identification efficiency.7, 14, 15
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On the other hand, bottom-up approaches involve digestion of excised protein
bands or spots after a gel-based electrophoresis separation or direct in-gel digestion without
spot excision. Spot visualization in the gel after separation requires staining procedures,
which are dependent on the physicochemical properties of the protein, such as molecular
weight, isoelectric point and solubility of the protein, and can limit the sensitivity for
visualization via staining.16 Compatibility and success of MS detection are also dependent
on the staining procedure. For example, coomassie blue stains are compatible with MS,
however, they are less sensitive than silver stains therefore restricting identification to only
the most abundant proteins in the gel. On the other hand, silver-stained proteins require
destaining before digestion to improve the sensitivity and quality of mass spectral data.17, 18
In general, regardless of the stain used, the efficiency and accuracy of protein identification
depends on the number of missed cleavages during digestion, protein abundance and
properties of the protein.18 In cases where protein spots are digested directly in the gel,
digestion is limited by the accessibility of the gel-entrapped proteins by the proteolytic
enzyme. Peptide fragments generated may diffuse into the gel media, which results in low
peptide recovery. Usually, careful peptide extraction from the gel is required in order to
improve peptide recovery and hence protein identification. These factors affect digestion
and typically results in less than 50 % sequence coverage when performing in-gel digestion.
Such low coverage affect for example the analysis of integral membrane proteins with
hydrophobic domains and post-translational modifications and because modified residues
may be excluded from the analysis, this may limit the protein identification efficiency.19, 20
However, in-gel digestion of proteins followed by peptide recovery is sometimes favored
over extraction of proteins from the gel followed by digestion. This is because protein

127

recovery from gels using electro-elution, chemical extraction or passive diffusion methods is
time-consuming and results in low protein yields, especially for low abundant proteins.21-23
Alternative approaches employ electroblotting to transfer gel free proteins onto membrane
supports.19, 24
In order to improve the efficiency of protein digestions and hence the reproducibility
of proteomic studies, there has been a shift in focus from solution-based or in-gel protein
digestion to immobilized microfluidic enzymatic reactors (IMERS).25-27 Immobilization of
proteolytic enzymes onto solid supports alleviates limitations encountered in solution-based
or in-gel protein digestion and results in less autodigestion of the enzyme, greater stability,
longer catalytic activity, reusability, and higher digestion efficiency.28-30 Reactors in microcolumn flow-through formats can be easily adapted into an integrated sample preparation
platform for automated sample processing.31 Enzymatic reactors have been prepared inside
microfluidic devices by immobilization of proteases onto polymer monoliths,32-34 beads,35, 36
and membranes,37-39 or encapsulation in sol-gels.40, 41 However, immobilization of protease
enzymes within, for example, a polymer monolith or encapsulation in sol-gels can
unfortunately limit or hinder substrate accessibility to the enzyme active sites, thereby
affecting the efficiency of the digestion. On the other hand, the use of beads in microfluidic
devices has been limited by difficulties encountered in packing the beads into the desired
locations within the chip as well as maintaining their entrapment when operated in flow
conditions.33, 42 Use of magnetic beads to simplify handling within a microfluidic device has
been shown to overcome some of the aforementioned problems associated with beads.36, 43,
44

Wang et.al reported a microfluidic-based reactor that was packed with immobilized

trypsin gel beads.35 Protein samples were flowed through the reactor using a syringe pump at
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rates between 0.5 and 1 µl/min, which afforded a digestion time of 3-6 min. In another
study, Ekstrom et.al demonstrated a reactor with trypsin immobilized onto a porous silicon
wafer for rapid protein digestion within 1 to 3 min.45 A membrane reactor consisting of
trypsin adsorbed onto poly-vinylidene fluoride (PVDF) membranes was used in a polydimethylsiloxane (PDMS) microfluidic device.37 Samples were flowed through the
membrane-based reactor using a syringe pump at rates of 0.3, 0.2 and 0.1 µl/min with
digestion times of 3, 5 and 10 min, respectively. Jin et.al described an electroosmotic flow
(EOF) driven reactor consisting of immobilized trypsin gel beads packed into a microfluidic
channel for digestion of proteins with a reaction time of 12 min.46
A compelling advantage of micro-reactors is that they can provide a large surface-tovolume ratio as a direct result of downscaling the micro-reactor bed volume.47 Decreasing
the linear dimension of the reactor reduces the surface area quadratically while the volume
decreases by the cube. The increased surface area-to-volume ratio results in reduced
diffusion paths and thus, increases encounters between the substrate and enzyme.48 This
phenomenon decreases kinetic barriers imposed by mass transport of substrate to the surface
resulting in shorter processing times for proteolytic digestion.47 For example, high aspect
ratio microstructures can provide increased surface area-to-volume ratios within a
miniaturized reactor with defined lateral dimensions and these structures can be embossed
inside the fluidic channel in situ using micro-replication technologies.26, 49-51 Patterning high
surface area support structures within the micro-reactor bed eliminates the difficulty
associated with packing beads and also allows the microstructures to be fixed in a desired
location within a device with an open architecture that provides unrestricted substrate access
to the immobilized enzyme.
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In this Chapter, we report on the fabrication, assembly and operational parameters of
a high surface area-to-volume ratio solid-phase micro-reactor consisting of a 3.5 cm x 230
µm x 100 µm microfluidic channel with trypsin immobilized onto an array of free-standing
30 µm x 30 µm diamond-shaped micro-post support structures with 20 µm edge-to-edge
interspacing embossed into a fluidic channel. The microchip was embossed in poly-methyl
methacrylate (PMMA) substrate from a metal master prepared using LiGA. The proteolytic
enzyme, trypsin, was covalently strapped to the surface of the PMMA microstructure
supports using a UV-directed surface modification protocol. The performance characteristics
of the solid-phase reactor were assessed using model proteins. The sequence coverage for
model proteins was optimized as a function of linear flow velocity, micro-reactor geometry,
physical and material properties of proteins and substrate respectively.
4.2

Experimental

4.2.1

Reagents and Materials

Proteomics grade tryspin (T-6567), cytochrome c (C-2506), myoglobin (M-1882), βcasein (C-6905), BSA (A-0281), α-cyano-4-hydroxycinamic acid (C-2020) and ammonium
bicarbonate (A-6141) were all obtained from Sigma Aldrich (St. Louis, MO) and used as
received without further purification. Sodium phosphate buffered saline pH 7.0 (PBS,
Product No. 28732), MES (2-[morpholino] ethanesulfonic acid) buffer (Product No.28390),
sulfo-NHS

(N-hydroxysuccinimide)

(Product

No.24510),

1-ethyl-3-[3-

dimethylaminopropyl] carbodiimide hydrochloride (EDC, Product No.22980) were obtained
from Pierce Biotechnology (Rockford, IL) and used as received without further
purifications. Polymethyl methacrylate (PMMA) sheets were obtained from MSC industrial
supply Co. (Melville, NY).
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4.2.2

Micro-reactor Fabrication

A mold master was prepared using the LiGA technique, which was subsequently used
to replicate polymer micro-parts via hot embossing as described in Chapter 3.52-54 The
embossed microfluidic devices had 16 micro-reactor chambers each consisting of a 3.5 cm
long x 230 µm wide x 100 µm deep microfluidic channel and an array of free standing 30
µm x 30 µm x 100 µm tall diamond-shaped microposts with a 20 µm edge-to-edge
interspacing embossed within the polymer fluidic channel bed. Figure 4.1 shows these
micro-post structures used in the micro-reactor to achieve the desired high surface area-tovolume ratio. There where approximately 2,500 posts in each bed which increased the
surface area-to-volume ratio of the chamber up to three times compared to that of a similar
dimensional open chamber without micro-posts. Two reservoirs of approximately 1 mm in
diameter were manually drilled at the start and end of each reactor, one to allow for liquid
introduction to the reactor chambers and another as the exit reservoir for collection.
4.2.3

UV Activation of PMMA and Trypsin Immobilization

After embossing, the microstructures were sonicated in water for 15 min then rinsed
with copious amounts of distilled water and air dried. The microstructures and cover plate
were then exposed to UV light at 254 nm for 20 min. A final rinse of the microstructures and
the cover plate was done with distilled water followed by air drying. The reactor chambers
were then enclosed by thermally annealing a cover plate at a controlled temperature of 102
0

C. The enzyme attachment protocol adopted was based on PMMA modification protocols

developed in our laboratories and is shown schematically in Figure 4.2.55,

56

A buffer

solution comprised of 0.1 M MES (2-[morpholino]ethanesulfonic acid) and 0.5 M NaCl at
pH 6.0 was used to prepare 5 mM of sulfo-NHS (N-hydroxysuccinimide) and 5 mM of 1-
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ethyl-3-[3-dimethylaminopropyl] carbodiimide hydrochloride (EDC) coupling reagent. This
solution was introduced into the micro-reactor chambers using a syringe and incubated
inside the reactor for 15 min. It was thereafter replaced with a 100 mM phosphate buffer
solution at pH 7.0 containing 100 µg of trypsin. After refilling the chamber, the reservoirs
were sealed with scotch tape to prevent evaporation and the solution was left to stand inside
the chambers for 2-3 h. The solution containing excess trypsin was removed from the
reactors; the chambers were then rinsed with buffer and air dried. After air drying, the
reactor chambers with immobilized trypsin were ready for use. A fused silica capillary was
then glued to each of the chamber entrance reservoir ports to allow protein solution to be
introduced into the chambers using a syringe pump.
4.2.4

Protein Digestions

Solutions containing 1 mg/ml of protein samples (cytochrome C, myoglobin, βcasein, and BSA) were prepared separately in 20 mM ammonium bicarbonate buffer at pH
7.0 and introduced into the micro-reactor chambers using a syringe pump (Harvard
Apparatus, model 55-2222). For each protein sample, the solution was flowed through the
micro-reactors at flow rates ranging from 2 to 10 µl/min. The residence time taken by the
fluid to travel inside the micro-reactor at a given volumetric flow rate was experimentally
determined by observing under a bright field microscopy. At 2 µl/min, the solution
residence time inside the micro-reactor was estimated to be 3.8 s while at 10 µl/min, the
residence time was 13.8 s. The solution at the exit reservoir was sampled by pipetting 0.5 µl
aliquots in a timely fashion using a syringe and deposited onto a MALDI sample target as
show in Figure 4.1. The MALDI matrix (α-cyano-4-hydroxycinamic acid, α-CHCA) was
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then added to the sample deposit followed by MALDI TOF MS analysis. Peptide masses
obtained were used to identify the proteins using MS-digest database searches.

Figure 4.1 Solid-phase micro-reactor chambers consisting of fluidic channels with free
standing micro-post patterned on the floor of the channel bed. The chamber measured 35
mm x 230 µm x 100 µm and had an array of 30 µm x 30 µm posts with 20 µm interspacing.
On one end was a fused capillary fit to introduce sample into the chamber and on the other
end was an open reservoir for sampling aliquots for deposition onto a MALDI sample target.

Figure 4.2 A three step protocol for immobilizing trypsin onto PMMA microstructures; (i)
UV exposure on native PMMA microstructures to introduce surface carboxylic groups; (ii)
activation of surface carboxylic groups with NHS/EDC; (iii) covalent coupling of amine
groups of trypsin onto the microstructures.
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4.3

Results and Discussion

Surface immobilization and test of activity. To evaluate the ability of trypsin when
immobilized onto PMMA microstructures to maintain its catalytic activity, we first tested
the immobilization protocol using a thin polymer sheet and exposed the immobilized trypsin
to the model proteins. A sheet of PMMA was activated with UV light at 254 nm for 15 min,
rinsed with copious amounts of distilled water and thereafter air dried. One µl of a buffer
solution containing 0.1 M MES, 0.5 M NaCl at pH 6.0, 5 mM sulfo-NHS (Nhydroxysuccinimide)

and

5

mM

1-ethyl-3-[3-dimethylaminopropyl]

carbodiimide

hydrochloride (EDC) was deposited on the polymer sheet and left to stand for 15 min. It was
then replaced with another 1 µl of a 100 mM phosphate buffer solution at pH 7.0 containing
100 µg of trypsin then covered to prevent evaporation and left to stand on the polymer sheet
for about 2-3 h. A schematic representation of the trypsin immobilization procedure is
shown in Figure 4.2. First, the methacrylate moieties on the native PMMA surface were
converted to carboxylic functional groups by exposure to UV light. The carboxylic groups
were

then

activated

by

sulfo-NHS

(N-hydroxysuccinimide)

and

1-ethyl-3-[3-

dimethylaminopropyl] carbodiimide hydrochloride (EDC), which served as the coupling
reagent. The primary amine groups present in trypsin were then coupled directly to the
carboxylic groups using EDC. After the coupling reaction was completed, the polymer sheet
was thoroughly rinsed with distilled water and dried under a stream of air.
After a matrix was deposited on the polymer sheet, the sheet was attached onto a
standard MALDI target using double-sided adhesive tape and the deposit was analyzed with
MALDI TOF MS. A mass spectrum acquired directly from the polymer sheet showed the
expected trypsin peak at ~ m/z 24,000 (see Figure 4.3). As deduced from this experiment,
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trypsin was successfully covalently immobilized onto the PMMA surface as shown in the
mass spectrum.

Figure 4.3 Mass spectra acquired on a PMMA surface a) before trypsin immobilization b)
after trypsin immobilization.

The activity of the immobilized trypsin was then evaluated by first depositing 1 µl of
a solution containing 1mg/ml of β-casein onto the trypsin immobilized polymer sheet. The
digestion was stopped after ~3 s by addition of trifluoroacetic acid followed by immediate
addition of a MALDI matrix. In the flow through format, a solution containing 1mg/ml of βcasein was introduced into the micro-reactor at a flow rate of 10 µl/min. The mass spectrum
in Figure 4.4a shows a ~3 s tryptic digestion of β-casein acquired on the polymer sheet and
Figure 4.4b shows a mass spectrum of a β-casein digested in the flow through micro-reactor
format. As can be seen in both cases, peptide fragments were generated and the mass of the
peaks observed agreed with the expected fragments from a tryptic digest of β-casein, an
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indication that the immobilized trypsin retained its enzymatic activity. However, digestion in
on the polymer sheet showed larger fragments an indication of incomplete digestion while
the digestion in the flow through reactor showed most of the fragments within the expected
m/z region for a complete digestion typical of β-casein.

Figure 4.4 Mass spectra data acquired from: (a) static digestion of β-casein on a polymer
sheet immobilized with trypsin; (B) flow through digestion of β-casein in a micro-reactor
with immobilized trypsin.

Flow through trypsin micro-reactors. In the micro-reactor format, test proteins were
digested by flowing them through the micro-reactor chamber containing the micro-posts
with immobilized trypsin at varying flow rates and hence, controlled residence times. The
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peptide fragments generated from the reactor were collected as fractions at the exit reservoir
and analyzed with a MALDI TOF MS by depositing the effluent of the micro-reactor onto a
MALDI target plate. The peptide fragments generated were identified using a MS-digest
database search and were used to compute the sequence coverage of the proteins. The
sequence coverage was calculated from the ratio of the number of identified amino acids to
the total number of amino acids present in the protein and reported as percent sequence
coverage. High sequence coverage indicated improved digestion and protein identification
efficiencies. The geometry of the proteolytic chamber was first investigated and digestion
efficiencies were compared. Three chambers with different geometries were tested: (i) a 35
mm long x 230 µm wide x 100 µm deep chamber that had an array of 30 µm x 30 µm
micro-posts with 20 µm interspacing; (ii) a chamber with same lateral dimensions as the
micro-reactor described in (i) above but without the micro-post architecture (open channel
format); and (iii) a 35 mm long x 50 µm wide x 100 µm deep open channel format chamber
without micro-posts. Figure 4.5 shows a comparison of sequence coverage obtained from
these three chambers of different geometries as a function of flow rate.
As seen in Figure 4.5, there was 60 to 100% enhancement in sequence coverage
using the chamber with the micro-post architecture as compared to the open channel
architecture of similar dimensions for the model protein, cytochrome c. Mass transport is
directly proportional to the diffusion coefficients and inversely proportional to the distance
the protein travels to encounter the immobilized enzyme. In the posted channel the mass
transport was increased due to the shortened distance that the protein in solution traveled to
encounter the immobilized trypsin. This resulted to more frequent encounters between the
solution-phase protein and the surface-immobilized enzyme. Further, the microstructures
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inside the reactor chamber provide increased surface area, which resulted in a higher trypsin
load compared to the open channel. The factors resulted in higher digestion efficiency and
better sequence coverage in the micro-posted chamber. The digestion efficiency is measured
by the substrate modulus, which is a ratio of reaction velocity to transport velocity. This
modulus is inversely proportional to rate of mass transport and approaches zero at high
transport velocity when mass transport is larger than rate of reaction. A modulus of zero
indicates the highest digestion efficiency since the reaction is limited by the enzyme
kinetics.

Figure 4.5 Evaluation of % sequence coverage for the test protein, cytochrome c, as a
function of flow rate in µl/min for different micro-reactor geometries.▲ represents open
chamber geometry of dimensions 35 mm x 230 µm x 100 µm without microposts, ♦
represents posted micro-reactor chamber of geometry similar to the open channel reactor
and ♦ represents open chamber geometry with 50 µm channel width but same length and
depth as the other chambers described above.
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An open-channel reactor with a 50 µm width (~5 times reduction in channel width
compared to the micro-reactors discussed above) but the same length and depth was also
tested for digestion efficiency. The results from this geometry indicated a 20% reduction in
sequence coverage compared to the large geometry micro-reactor with micro-posts, but a 40
to 60% enhancement compared to the large geometry without micro-posts. These results are
consistent with lower mass transport and trypsin load in the case of the large geometry
without micro-posts and also indicate that the micro-posted chamber provided higher mass
transport and surface area for loading trypsin with unrestricted enzyme access to the protein
in solution.
The effects of flow rates were investigated by flowing protein solutions through the
reactor chamber at varying flow rates. Figure 4.6 shows a plot of flow rate and residence
time as a function of sequence coverage for the model protein, myoglobin. As indicated in
this plot, short residence times afforded higher sequence coverage and therefore, improved
protein identification efficiency compared to longer residence times. The high surface areato-volume ratio architecture of the reactor chamber was used since it minimized the
diffusion paths and allowed increased substrate-enzyme encounters. At high flow rates,
peptide fragments generated inside the chamber were rapidly flowed out to the exit reservoir
spending less time in the chamber. The adsorption of peptide fragments onto the
microstructures or fluidic wall was minimized at high flow rates. Indeed according to stokes
law, the hydrodynamic shear forces (F) experienced by the fragments was directly
proportional to the fluid stream linear velocity (ν), F ∝ ν.57 At high flow rates, the strength
of the hydrodynamic shear forces were greater than the strength of adsorption forces.
Addressing the reactor chamber in a flow-through format at high flow rates allowed
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operation such that the substrate residence time, tr, was greater than the initial substratetrypsin complex formation rate, k1 , and turnover rates, kcat , which typically occur in the
millisecond time scale (kcat + k1<< tr). However, the rate of mass transport was higher than
turnover rate in the reactor chamber and therefore the digestion efficiency was controlled by
the enzyme kinetics.

Figure 4.6 A plot of percent sequence coverage for a model protein myoglobin as a function
of flow rate in µl/min and residence time in sec. At high flow rates (short residence time) the
sequence coverage was high compared to low flow rates.

At lower flow rates, the sequence coverage was reduced due to increased peptide
adsorption onto the microstructures. The flow through format alleviated the digestion
inefficiency typical of solution phase protocols that result from chemical modifications,4, 7, 9,
10, 14, 15

or possible inhibition of trypsin activity by the generated peptide fragments.7, 8, 11-13
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Such factors in addition to fragments adhering onto microstructures could account for the
reduced sequence coverage that was observed at lower flow rates or longer residence times
in the reactor chamber.
Two types of PMMA material were investigated for these studies, gray PMMA and
clear PMMA. Structurally, the two types of PMMA materials are the same however, they
exhibit different physical properties. Gray PMMA has a higher wettability (contact angle of
270 ± 2) and thus is more hydrophilic compared to clear PMMA (contact angle of 730 ±3
).58 Further, the optical clarity of the two materials is different, gray PMMA absorbs more
UV light than clear PMMA.58 Figure 4.7 shows the effects of the substrate on sequence
coverage as a function of flow rate.

Figure 4.7 A plot of percent sequence coverage for the model protein myoglobin as a
function of flow rate in µl/min for two PMMA materials. ■ represents the more hydrophilic
gray PMMA while ● represents the more hydrophobic clear PMMA.
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At higher flow rates, the differences in sequence coverage for both materials
appeared to be negligible, however at lower flow rates, there appeared to be a more
pronounced difference with the gray PMMA showing higher sequence coverage compared
to the clear PMMA. A possible explanation for this phenomenon lies in the differences of
the material properties. Because gray PMMA absorbed more UV radiation than clear
PMMA,58 this could result in more carboxylic groups on the surface.59 In turn, more enzyme
was therefore loaded onto the microstructures for gray PMMA compared to clear PMMA,
resulting in differences in enzyme activity per unit area and hence the sequence coverage. At
lower flow rates, the enzyme activity per unit area was controlled by the rate of mass
transport while at higher flow rates it was controlled by the enzyme kinetics.
Although the contact angle slight decreases upon exposure to UV light, rinsing the
surface removes the monolayer of photochemically modified low molecular weight polymer,
restoring the contact angle close to the original value and introducing an increase in surface
roughness.59-61 According to Young’s equation, the difference in contact angles of the
PMMA materials indicate that gray PMMA had more surface energy than clear PMMA.62
Since the wettability of a surface is governed by the surface energy and roughness,63, 64 the
propensity of generated peptides to adhere to the microstructures was high for the
hydrophobic low surface energy clear PMMA. However, at higher flow rates, the substrate
effects were negligible because the hydrodynamic shear forces experienced by the generated
peptide fragments at high velocities would remove adsorbed peptides within the microreactor.
The model proteins were all water soluble however they varied in MW from 12 kDa
to 69 kDa and in pI from 5.3 to 9.6 as shown in Table 4.1. At the shortest residence time of
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3.8 s, the model proteins demonstrated a molecular weight dependency on the sequence
coverage. Smaller proteins, like cytochrome c, with a MW of 12,348 Da showed 100 %
sequence coverage while for larger proteins like BSA, with a MW of 69,294 Da, lower
sequence coverage was observed. This is an indication that the ease of digestion is also
dependent on other properties of the protein. For example, the molecular weight, structure
and isoelectric point of the protein in question. Structurally, these proteins are also different
with cytochrome c having predominantly a secondary structure while BSA has a tertiary
structure. Tertiary structures are stabilized by disulphide bonds making cleavage sites
inaccessible by proteolytic enzymes and are therefore difficult to digest
Table 4.1 A list of test proteins with their MW and the computed percent sequence coverage
at the same residence time inside the micro-posted chamber.

Protein

Molecular weight

Isoelectric Point

Residence Time

Sequence Coverage

(Mw, Da)

(pI)

(sec)

(Percent, %)

Cytochrome c

12348

9.6

3.85

100

Myoglobin

16954

7.4

3.85

90

β-casein

25108

5.3

3.85

60

BSA

69294

5.8

3.85

50

4.4

Conclusions

Solid-phase flow through digestion of proteins has been demonstrated in a microreactor that provided high digestion efficiency and allowed for improved protein
identification efficiencies without performing tandem MS on the peptide fragment peaks.
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The digestion was accomplished using a high surface area-to-volume ratio chamber with
surface immobilized trypsin on microstructures. The chamber afforded fast digestion (4 s) of
model proteins with sequence coverage that was found to depend on the molecular weight.
For example, with ~ 4 s digestion of cytochrome c, which has a molecular weight of 12,348
Da, the peptide map generated 100 % sequence coverage information. The geometry of the
chamber was found to significantly affect the efficiency of digestion. At the same time, the
material properties of the chamber were found to affect the sequence information depending
on the residence time. Physical properties like MW, pI and structure of the model proteins
were also found to affect the efficiency of digestion.
4.5
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CHAPTER 5: FUTURE WORK
5.1

An Integrated Sample Processing Microfluidic System for Protein Analysis

As mentioned in Chapter 1, we are developing an integrated sample processing
system for protein analysis that can be interfaced to a variety of different biological mass
spectrometers (MS), such as MALDI or ESI. The system was comprised of a protein
extraction and pre-concentration unit connected to a fluidic network for two-dimensional
separations of proteins extracted from the first unit. The two-dimensional protein separation
unit was connected to another module consisting of a series of solid phase micro-reactors
arrayed parallel to each other for proteolytic cleavage of individual protein bands separated
from the two-dimensional unit. The reactors were connected to a downstream separation unit
for sorting peptide fragments that are finally introduced into a mass spectrometer for protein
identification. A schematic diagram for the integrated sample processing system is shown in
Figure 5.1.

Figure 5.1 A schematic diagram illustrating an integrated sample processing system with
four units; unit I performs protein extraction and pre-concentration; unit II is for twodimensional separation of proteins; unit II does proteolytic digestion of individual protein;
and unit IV separates peptide fragments before they are introduced into the MS for protein
identification.
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The system will be tested by introducing whole cells that were lysed and the protein
components extracted and pre-concentrated from cellular matrix using nanopillars decorated
with a thermally-responsive polymer, poly (N-isopropylacrylamide) (pNIPAAm). This
polymer exhibited reversible wettability and protein adsorption properties that can be
exploited to capture and release proteins from solution. Above its liquid critical solution
temperature (LCST), the polymer is hydrophobic and below its LCST, the polymer is
extremely hydrophilic, therefore acting as an on-off switch to pre-concentrate extracted
proteins in the channel. Extracted proteins were then be injected to the two-dimensional
separation unit. In this unit, microchip gel electrophoresis and micellar electrokinetic
chromatography will be used for protein separation. Two conductivity sensors will be used
to monitor separations in this unit. Protein bands eluting from the second dimension were
injected into individual solid-phase micro-reactors for digestion. The solid phase microreactors will consist of trypsin immobilized onto high surface area micro-posts for rapid
digestion. Peptide fragments generated from these micro-reactors will be further separated
downstream using microchip electrochromatography or free solution electrophoresis. The
fragments detected using MALDI MS could be used for proteins identification using peptide
mass fingerprinting.
5.2

Experimental Section

To produce the prerequisite structures, PMMA was hot-embossed from a brass mold
master fabricated using high-precision micromilling.3 The nano-reactors and solid-phase
extraction bed contained nanopillar arrays situated within a micro-channel and were
fabricated using a nano-templating technique.4 A patterned anodic alumina oxide (AAO)
template supported by aluminum, which was shadow printed via Ar ion sputtering of an Al
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target into the appropriate locations within the fluidic network, was ultra-sonicated followed
by filling the nanopores with methyl methacrylate (MMA) monomer containing benzoin
methyl ether and 1% PMMA powder. The polymerization occurred under UV-254 nm light
with the sacrificial AAO template removed using phosphoric acid and a freezing drying
technique. Trypsin was surface-immobilized onto the nanopillar structures following UV254 nm exposure and incubation with 1-ethyl-3-[3-dimethylaminopropyl] carbodiimide
hydrochloride (EDC). For protein capture, the nanopillars were dynamically coated with
poly(N-isopropylacrylamide), pNIPPAm. Meso-scale pNIPPAm films have contact angles
of 71o above its liquid critical solution temperature (LCST) and 50o below.
5.3

Results and Discussion

To affect isolation of a series of proteins from whole cell lysates, nanopillar arrays
(see Figure 5.2A) were dynamically coated with pNIPPAm, which showed superhydrophobicity at a temperature above its LCST (contact angle ~90o) and superhydrophilicity below its LCST (contact angle ~0o), which served as a highly efficient solidphase capture-bed for hydrophobic proteins (see Figure 5.2B).
(B)
(A)

Figure 5.2 (A) Micrographs of high aspect ratio (>340) nanopillars fabricated by nanotemplating using AAO. The pillars were 60 µm in height and 175 nm in diameter with a 285
nm edge-to-edge spacing, (B) Nanopillars that were dynamically coated with pNIPPAm and
used to capture avidin that was labeled with a fluorescent dye. The first image shows the
material above its LCST, in which the protein is captured and the second micrograph shows
the release of avidin by dropping the temperature below the LCST.
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Following protein isolation, a 2D SDS µ-CGE x MEKC separation was performed,
which produced an efficiency, resolution and peak capacity of >105 plates, >4 and ~897,
respectively (see Figure 5.3A).1 The sorted protein components were then digested using a
nanopillar-based solid-phase proteolytic reactor. The proteolytic nano-reactor was tested
with several proteins to evaluate its performance, which indicated high protein identification
efficiencies due to fast (<4 s digestion times) and efficient (>80% sequence coverage)
proteolytic digestions (see Figure 5.3B).

(B)

(A)

Figure 5.3 (A) 2D SDS µ-CGE x MEKC electrophoretic separation of proteins. The
detection was accomplished using laser-induced fluorescence of proteins labeled with
Alexa-Fluor 633. (B) Mass spectrum showing the MALDI-TOF-MS analyses of peptides
fragments generated from cytochrome C that were subjected to solid-phase proteolytic
digestion using trypsin immobilized onto nanopillars

The generated peptides from the proteolytic digestion could be separated using µCEC of the peptide fragments by coating the PMMA surface with a C18 hydrophobic phase
following UV-activation of the PMMA surface to create a functional scaffold of carboxylate
groups. Since there could be more than one protein in each band from the second dimension
that is injected into the nano-reactors, a peptide separation step that simplifies the fragment
mixture is necessary in order to improve the protein identification process. The automated
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analysis could be completed by interfacing the microfluidic system to MALDI MS via a
rotating ball interface.5 Peptide mass maps obtained from MALDI MS could be used to
identify the proteins present in the sample.
5.4

Conclusions

We are evaluating the design and performance of the integrated polymer-based
microfluidic system consisting of mixed-scale structures for analyzing proteins in an
automated fashion. The system can be multiplexed for high-throughput analyses and has the
potential for accelerating biomarker discovery and performing diagnostics.
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